Document:

EX-4.13

 Exhibit 4.13 

ORACLE CORPORATION 

Officers’ Certificate 

Reference is made to the Indenture dated as of January 13, 2006 (the “Base Indenture”) by and among Oracle
Corporation (the “Issuer,” formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007
(together with the Base Indenture, the “Indenture”) by and among the Issuer, Citibank, N.A. and The Bank of New York Trust Company, N.A. On June 29, 2007, Citibank, N.A. resigned as the original trustee under the Indenture and
the Issuer appointed The Bank of New York Trust Company, N.A. as successor trustee. Thereafter, The Bank of New York Trust Company, N.A. became The Bank of New York Mellon Trust Company, N.A. (the “Trustee”). The Trustee is the
trustee for any and all securities issued under the Indenture. Pursuant to Section 2.01 and Section 2.03 of the Base Indenture, the undersigned officers do hereby certify, in connection with the issuance of (i) $2,500,000,000
aggregate principal amount of 2.500% Notes due 2022 (the “2022 Notes”), (ii) $2,500,000,000 aggregate principal amount of 2.950% Notes due 2025 (the “2025 Notes”), (iii) $500,000,000 aggregate principal
amount of 3.250% Notes due 2030 (the “2030 Notes”), (iv) $1,250,000,000 aggregate principal amount of 3.900% Notes due 2035 (the “2035 Notes”), (v) $2,000,000,000 aggregate principal amount of 4.125% Notes
due 2045 (the “2045 Notes”) and (vi) $1,250,000,000 aggregate principal amount of 4.375% Notes due 2055 (the “2055 Notes” and, together with the 2022 Notes, the 2025 Notes, the 2030 Notes, the 2035 Notes and
the 2045 Notes, the “Notes”), that the terms of the Notes are as follows: 
 Capitalized terms used but not
otherwise defined herein shall have the meanings specified in the Indenture. 
 2022 Notes 

 

			
	Title:		2.500% Notes due 2022
		
	Issuer:		Oracle Corporation
		
	Trustee, Registrar, Transfer Agent, Authenticating Agent, and Paying Agent:		The Bank of New York Mellon Trust Company, N.A.
		
	Aggregate Principal Amount at Maturity:		$2,500,000,000
		
	Principal Payment Date:		May 15, 2022
		
	Interest:		2.500% per annum
		
	Date from which Interest will Accrue:		May 5, 2015

			
	Interest Payment Dates:		May 15 and November 15, commencing on November 15
		
	Redemption:		 The Issuer may, at its option, redeem the 2022 Notes in whole or in part, at any time or from time to time prior to March 15, 2022 (two
months prior to the maturity date), on at least 30 days, but not more than 60 days, prior notice sent to the registered address of each holder of the 2022 Notes, at a redemption price calculated by the Issuer equal to the greater of:

 
 (i) 100% of the principal amount of the 2022 Notes being redeemed; and

 
 (ii) the sum of the present values of the remaining scheduled payments of principal and
interest that would be due but for the redemption if the 2022 Notes matured on March 15, 2022 (exclusive of interest accrued as of the date of redemption) discounted to the redemption date on a semiannual basis (assuming a 360-day year
consisting of twelve 30-day months) of the 2022 Notes being redeemed at the Treasury Rate (as defined in the 2022 Notes) plus 12.5 basis points,
  

plus, in each case, accrued and unpaid interest thereon to the date of redemption.
  

The Issuer may, at its option, redeem the 2022 Notes in whole or in part, at any time on or after March 15, 2022 (two months prior to the maturity date), at a
redemption price calculated by the Issuer equal to 100% of the principal amount of the 2022 Notes to be redeemed, plus accrued and unpaid interest thereon to the date of redemption.

		
	Conversion:		None
		
	Sinking Fund:		None
		
	Denominations:		$2,000 and multiples of $1,000 thereafter
		
	Miscellaneous:		The terms of the 2022 Notes shall include such other terms as are set forth in the form of 2022 Notes attached hereto as Exhibit A and in the Indenture.

  
 2 

 2025 Notes 
  

			
	Title:		2.950% Notes due 2025
		
	Issuer:		Oracle Corporation
		
	Trustee, Registrar, Transfer Agent, Authenticating Agent, and Paying Agent:		The Bank of New York Mellon Trust Company, N.A.
		
	Aggregate Principal Amount at Maturity:		$2,500,000,000
		
	Principal Payment Date:		May 15, 2025
		
	Interest:		2.950% per annum
		
	Date from which Interest will Accrue:		May 5, 2015
		
	Interest Payment Dates:		May 15 and November 15, commencing on November 15
		
	Redemption:		 The Issuer may, at its option, redeem the 2025 Notes in whole or in part, at any time or from time to time prior to February 15, 2025
(three months prior to the maturity date), on at least 30 days, but not more than 60 days, prior notice sent to the registered address of each holder of the 2025 Notes, at a redemption price calculated by the Issuer equal to the greater of:

 
 (i) 100% of the principal amount of the 2025 Notes being redeemed; and

 
 (ii) the sum of the present values of the remaining scheduled payments of principal and
interest that would be due but for the redemption if the 2025 Notes matured on February 15, 2025 (exclusive of interest accrued as of the date of redemption) discounted to the redemption date on a semiannual basis (assuming a 360-day year consisting
of twelve 30-day months) of the 2025 Notes being redeemed at the Treasury Rate (as defined in the 2025 Notes) plus 15 basis points,
  

plus, in each case, accrued and unpaid interest thereon to the date of redemption.
  

The Issuer may, at its option, redeem the 2025 Notes in

  
 3 

			
			whole or in part, at any time on or after February 15, 2025 (three months prior to the maturity date), at a redemption price calculated by the Issuer equal to 100% of the principal amount of the 2025 Notes to be redeemed,
plus accrued and unpaid interest thereon to the date of redemption.
		
	Conversion:		None
		
	Sinking Fund:		None
		
	Denominations:		$2,000 and multiples of $1,000 thereafter
		
	Miscellaneous:		The terms of the 2025 Notes shall include such other terms as are set forth in the form of 2025 Notes attached hereto as Exhibit B and in the Indenture.

 2030 Notes 
  

			
	Title:		3.250% Notes due 2030
		
	Issuer:		Oracle Corporation
		
	Trustee, Registrar, Transfer Agent, Authenticating Agent, and Paying Agent:		The Bank of New York Mellon Trust Company, N.A.
		
	Aggregate Principal Amount at Maturity:		$500,000,000
		
	Principal Payment Date:		May 15, 2030
		
	Interest:		3.250% per annum
		
	Date from which Interest will Accrue:		May 5, 2015
		
	Interest Payment Dates:		May 15 and November 15, commencing on November 15
		
	Redemption:		The Issuer may, at its option, redeem the 2030 Notes in whole or in part, at any time or from time to time prior to February 15, 2030 (three months prior to the maturity date), on at least 30 days, but not more than 60 days,
prior notice sent to the registered address of each holder of the 2030 Notes, at a redemption price calculated by the Issuer equal to the greater of:

  
 4 

			
			 (i) 100% of the principal amount of the 2030 Notes being redeemed; and

 
 (ii) the sum of the present values of the remaining scheduled payments of principal and
interest that would be due but for the redemption if the 2030 Notes matured on February 15, 2030 (exclusive of interest accrued as of the date of redemption) discounted to the redemption date on a semiannual basis (assuming a 360-day year
consisting of twelve 30-day months) of the 2030 Notes being redeemed at the Treasury Rate (as defined in the 2030 Notes) plus 20 basis points,
  

plus, in each case, accrued and unpaid interest thereon to the date of redemption.
  

The Issuer may, at its option, redeem the 2030 Notes in whole or in part, at any time on or after February 15, 2030 (three months prior to the maturity
date), at a redemption price calculated by the Issuer equal to 100% of the principal amount of the 2030 Notes to be redeemed, plus accrued and unpaid interest thereon to the date of redemption.

		
	Conversion:		None
		
	Sinking Fund:		None
		
	Denominations:		$2,000 and multiples of $1,000 thereafter
		
	Miscellaneous:		The terms of the 2030 Notes shall include such other terms as are set forth in the form of 2030 Notes attached hereto as Exhibit C and in the Indenture.

 2035 Notes 
  

			
	Title:		3.900% Notes due 2035
		
	Issuer:		Oracle Corporation
		
	Trustee, Registrar, Transfer Agent, Authenticating Agent, and Paying Agent:		The Bank of New York Mellon Trust Company, N.A.
		
	Aggregate Principal Amount at Maturity:		$1,250,000,000

  
 5 

			
	Principal Payment Date:		May 15, 2035
		
	Interest:		3.900% per annum
		
	Date from which Interest will Accrue:		May 5, 2015
		
	Interest Payment Dates:		May 15 and November 15, commencing on November 15
		
	Redemption:		 The Issuer may, at its option, redeem the 2035 Notes in whole or in part, at any time or from time to time prior to November 15, 2034 (six
months prior to the maturity date), on at least 30 days, but not more than 60 days, prior notice sent to the registered address of each holder of the 2035 Notes, at a redemption price calculated by the Issuer equal to the greater of:

 
 (i) 100% of the principal amount of the 2035 Notes being redeemed; and

 
 (ii) the sum of the present values of the remaining scheduled payments of principal and
interest that would be due but for the redemption if the 2035 Notes matured on November 15, 2034 (exclusive of interest accrued as of the date of redemption) discounted to the redemption date on a semiannual basis (assuming a 360-day year consisting
of twelve 30-day months) of the 2035 Notes being redeemed at the Treasury Rate (as defined in the 2035 Notes) plus 20 basis points,
  

plus, in each case, accrued and unpaid interest thereon to the date of redemption.
  

The Issuer may, at its option, redeem the 2035 Notes in whole or in part, at any time on or after November 15, 2034 (six months prior to the maturity date), at
a redemption price calculated by the Issuer equal to 100% of the principal amount of the 2035 Notes to be redeemed, plus accrued and unpaid interest thereon to the date of redemption.

		
	Conversion:		None
		
	Sinking Fund:		None
		
	Denominations:		$2,000 and multiples of $1,000 thereafter

  
 6 

			
	Miscellaneous:		The terms of the 2035 Notes shall include such other terms as are set forth in the form of 2035 Notes attached hereto as Exhibit D and in the Indenture.

 2045 Notes 
  

			
	Title:		4.125% Notes due 2045
		
	Issuer:		Oracle Corporation
		
	Trustee, Registrar, Transfer Agent, Authenticating Agent, and Paying Agent:		The Bank of New York Mellon Trust Company, N.A.
		
	Aggregate Principal Amount at Maturity:		$2,000,000,000
		
	Principal Payment Date:		May 15, 2045
		
	Interest:		4.125% per annum
		
	Date from which Interest will Accrue:		May 5, 2015
		
	Interest Payment Dates:		May 15 and November 15, commencing on November 15
		
	Redemption:		 The Issuer may, at its option, redeem the 2045 Notes in whole or in part, at any time or from time to time prior to November 15, 2044 (six
months prior to the maturity date), on at least 30 days, but not more than 60 days, prior notice sent to the registered address of each holder of the 2045 Notes, at a redemption price calculated by the Issuer equal to the greater of:

 
 (i) 100% of the principal amount of the 2045 Notes being redeemed; and

 
 (ii) the sum of the present values of the remaining scheduled payments of principal and
interest that would be due but for the redemption if the 2045 Notes matured on November 15, 2044 (exclusive of interest accrued as of the date of redemption) discounted to the redemption date on a semiannual basis (assuming a 360-day year
consisting of twelve 30-day months) of the 2045 Notes being redeemed at the Treasury Rate (as defined in the 2045 Notes) plus 25 basis points,
  

plus, in each case, accrued and unpaid interest thereon to the date of redemption.

  
 7 

			
			The Issuer may, at its option, redeem the 2045 Notes in whole or in part, at any time on or after November 15, 2044 (six months prior to the maturity date), at a redemption price calculated by the Issuer equal to 100% of the
principal amount of the 2045 Notes to be redeemed, plus accrued and unpaid interest thereon to the date of redemption.
		
	Conversion:		None
		
	Sinking Fund:		None
		
	Denominations:		$2,000 and multiples of $1,000 thereafter
		
	Miscellaneous:		The terms of the 2045 Notes shall include such other terms as are set forth in the form of 2045 Notes attached hereto as Exhibit E and in the Indenture.

 2055 Notes 
  

			
	Title:		4.375% Notes due 2055
		
	Issuer:		Oracle Corporation
		
	Trustee, Registrar, Transfer Agent, Authenticating Agent, and Paying Agent:		The Bank of New York Mellon Trust Company, N.A.
		
	Aggregate Principal Amount at Maturity:		$1,250,000,000
		
	Principal Payment Date:		May 15, 2055
		
	Interest:		4.375% per annum
		
	Date from which Interest will Accrue:		May 5, 2015
		
	Interest Payment Dates:		May 15 and November 15, commencing on November 15
		
	Redemption:		The Issuer may, at its option, redeem the 2055 Notes in whole or in part, at any time or from time to time prior to November 15, 2054 (six months prior to the maturity date), on at least 30 days, but not more than 60
days,

  
 8 

			
			 prior notice sent to the registered address of each holder of the 2055 Notes, at a redemption price calculated by the Issuer equal to the
greater of:
  
 (i) 100% of the principal amount of the 2055 Notes being redeemed;
and
  
 (ii) the sum of the present values of the remaining scheduled payments of
principal and interest that would be due but for the redemption if the 2055 Notes matured on November 15, 2054 (exclusive of interest accrued as of the date of redemption) discounted to the redemption date on a semiannual basis (assuming a
360-day year consisting of twelve 30-day months) of the 2055 Notes being redeemed at the Treasury Rate (as defined in the 2055 Notes) plus 30 basis points,
  

plus, in each case, accrued and unpaid interest thereon to the date of redemption.
  

The Issuer may, at its option, redeem the 2055 Notes in whole or in part, at any time on or after November 15, 2054 (six months prior to the maturity
date), at a redemption price calculated by the Issuer equal to 100% of the principal amount of the 2055 Notes to be redeemed, plus accrued and unpaid interest thereon to the date of redemption.

		
	Conversion:		None
		
	Sinking Fund:		None
		
	Denominations:		$2,000 and multiples of $1,000 thereafter
		
	Miscellaneous:		The terms of the 2055 Notes shall include such other terms as are set forth in the form of 2055 Notes attached hereto as Exhibit F and in the Indenture.

 Subject to the representations, warranties and covenants described in the Indenture, as amended or
supplemented from time to time, the Issuer shall be entitled, subject to authorization by the Board of Directors of the Issuer and an Officers’ Certificate, to issue additional notes from time to time under each series of notes issued hereby.
Any such additional notes of a series shall have identical terms as the 2022 Notes, the 2025 Notes, the 2030 Notes, the 2035 Notes, the 2045 Notes or the 2055 Notes, as the case may be, issued on the issue date, other than with respect to the date
of issuance and the issue price (together the “Additional Notes”). Any Additional Notes will be issued in accordance with Section 2.03 of the Base Indenture. 

  
 9 

 Each such officer has read and understands the provisions of the Indenture and the definitions
relating thereto. The statements made in this Officers’ Certificate are based upon the examination of the provisions of the Indenture and upon the relevant books and records of the Issuer. In such officers’ opinion, they have made such
examination or investigation as is necessary to enable such officers to express an informed opinion as to whether or not the covenants and conditions of such Indenture relating to the issuance and authentication of the Notes have been complied with.
In such officers’ opinion, such covenants and conditions have been complied with. 

  
 10 

 IN WITNESS WHEREOF the undersigned officers of the Issuer have duly executed this certificate as
of May 5, 2015. 
  

					
	ORACLE CORPORATION
		
	By:		  

			Name:		Safra A. Catz
			Title:		Chief Executive Officer
		
	By:		  

			Name:		Eric R. Ball
			Title:		Senior Vice President and Treasurer

 [Signature Page to Officers’ Certificate Pursuant to the Indenture] 

  
 11 

 EXHIBIT A 

[FORM OF 2.500% NOTES DUE 2022] 

UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
(“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC
(AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN. 
 TRANSFERS OF THIS NOTE ARE LIMITED TO TRANSFERS IN
WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS OF THE INDENTURE. 

IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH
TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 

  
 12 

 ORACLE CORPORATION 

2.500% Notes due 2022 
  

			
	No.		CUSIP No.: 68389X BB0
			ISIN No.: US68389XBB01
		
			$            

 ORACLE CORPORATION, a Delaware corporation (the “Issuer”), for value received promises
to pay to CEDE & CO. or registered assigns the principal sum of                     DOLLARS on May 15, 2022. 

Interest Payment Dates: May 15 and November 15 (each, an “Interest Payment Date”), commencing on November 15,
2015. 
 Interest Record Dates: April 30 and October 31 (each, an “Interest Record Date”). 

Reference is made to the further provisions of this Note contained herein, which will for all purposes have the same effect as if set forth at
this place. 

  
 13 

 IN WITNESS WHEREOF, the Issuer has caused this Note to be signed manually or by facsimile by its
duly authorized officers. 
  

					
	ORACLE CORPORATION
		
	By:		  

			Name:		Safra A. Catz
			Title:		Chief Executive Officer
		
	 By:
		  

			Name:		Eric R. Ball
			Title:		Senior Vice President and Treasurer

  
 14 

 This is one of the Notes of the series designated herein and referred to in the within-mentioned
Indenture. 
 Dated: May 5, 2015 
  

			
	The Bank of New York Mellon Trust Company, N.A., as Trustee
		
	By:		  

			Authorized Signatory

  
 15 

 (REVERSE OF NOTE) 

ORACLE CORPORATION 
 2.500% Notes
due 2022 
 1. Interest 

Oracle Corporation (the “Issuer”) promises to pay interest on the principal amount of this Note at the rate per annum
described above. Cash interest on the Notes will accrue from the most recent date to which interest has been paid; or, if no interest has been paid, from May 5, 2015. Interest on this Note will be paid to but excluding the relevant Interest
Payment Date. The Issuer will pay interest semi-annually in arrears on each Interest Payment Date, commencing November 15, 2015. Interest will be computed on the basis of a 360-day year consisting of twelve 30-day months in a manner consistent
with Rule 11620(b) of the FINRA Uniform Practice Code. 
 The Issuer shall pay interest on overdue principal from time to time on
demand at the rate borne by the Notes and on overdue installments of interest (without regard to any applicable grace periods) to the extent lawful. 

2. Paying Agent. 

Initially, The Bank of New York Mellon Trust Company, N.A. (the “Trustee”) will act as paying agent. The Issuer may
change any paying agent without notice to the Holders. 
 3. Indenture; Defined Terms. 

This Note is one of the 2.500% Notes due 2022 (the “Notes”) issued under an indenture dated as of January 13,
2006 (the “Base Indenture”) by and among the Issuer (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by a supplemental indenture dated as of
May 9, 2007 (together with the Base Indenture, the “Indenture”) by and among the Issuer, Citibank, N.A. and the Trustee, and established pursuant to an Officers’ Certificate dated May 5, 2015, issued pursuant to
Section 2.01 and Section 2.03 of the Base Indenture. This Note is a “Security” and the Notes are “Securities” under the Indenture. 

For purposes of this Note, unless otherwise defined herein, capitalized terms herein are used as defined in the Indenture. The terms of
the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa-77bbbb) (the “TIA”) as in effect on the date on which the Indenture was
qualified under the TIA. Notwithstanding anything to the contrary herein, the Notes are subject to all such terms, and holders of Notes are referred to the Indenture and the TIA for a statement of them. To the extent the terms of the Indenture and
this Note are inconsistent, the terms of the Indenture shall govern. 

  
 16 

 4. Denominations; Transfer; Exchange. 

The Notes are in registered form, without coupons, in denominations of $2,000 and multiples of $1,000 thereafter. A Holder shall register the
transfer or exchange of Notes in accordance with the Indenture. The Issuer may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay certain transfer taxes or similar governmental charges payable
in connection therewith as permitted by the Indenture. The Issuer need not issue, authenticate, register the transfer of or exchange any Notes or portions thereof for a period of fifteen (15) days before the sending of a notice of redemption,
nor need the Issuer register the transfer or exchange of any Note selected for redemption in whole or in part. 
 5. Amendment; Supplement;
Waiver. 
 Subject to certain exceptions, the Notes and the provisions of the Indenture relating to the Notes may be amended or supplemented
and any existing default or Event of Default or compliance with certain provisions may be waived with the written consent of the Holders of at least a majority in aggregate principal amount of all series of Outstanding Securities (including the
Notes) under the Indenture that are affected by such amendment, supplement or waiver (voting as a single class). Without notice to or consent of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other
things, cure any ambiguity, defect or inconsistency or comply with any requirements of the Commission in connection with the qualification of the Indenture under the TIA, or make any other change that does not adversely affect the rights of any
Holder of a Note. 
 6. Redemption. 

The Issuer may at its option redeem any of the Notes in whole or in part at any time prior to March 15, 2022 (two months prior to the
maturity date), each at a redemption price calculated by the Issuer equal to the greater of: 
 (i) 100% of the principal amount of the
Notes to be redeemed; and 
 (ii) the sum of the present values of the remaining scheduled payments of principal and interest that would be
due but for the redemption if the Notes matured on March 15, 2022 (not including any portion of such payments of interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day
year consisting of twelve 30-day months) at the Treasury Rate (as defined below) plus 12.5 basis points, 
 plus in each case accrued and unpaid interest
thereon to the date of redemption. 
 At any time on or after March 15, 2022 (two months prior to the maturity date), the Notes will be
redeemable, in whole or in part, at the Issuer’s option, at a redemption price calculated by the Issuer equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest thereon to the date of redemption. 

Notwithstanding the foregoing, installments of interest on Notes that are due and payable on interest payment dates falling on or prior to a
redemption date will be payable on the interest payment date to the registered Holders as of the close of business on the relevant record date according to the Notes and the Indenture. 

  
 17 

 “Comparable Treasury Issue” means the United States Treasury security or
securities selected by the Quotation Agent as having an actual or interpolated maturity comparable to the remaining term of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial
practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the Notes. 

“Comparable Treasury Price” means, with respect to any redemption date, (i) the average of four Reference
Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Quotation Agent obtains fewer than four such Reference Treasury Dealer Quotations, the average
of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, such quotation. 

“Quotation Agent” means the Reference Treasury Dealer appointed by the Issuer. 

“Reference Treasury Dealer” means (i) J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith
Incorporated and a Primary Treasury Dealer (defined herein) selected by Wells Fargo Securities, LLC (or their respective affiliates that are Primary Treasury Dealers) and their respective successors; provided, however, that if
any of the foregoing shall cease to be a primary U.S. Government securities dealer in New York City (a “Primary Treasury Dealer”), the Issuer will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary
Treasury Dealer selected by the Issuer. 
 “Reference Treasury Dealer Quotations” means, with respect to each
Reference Treasury Dealer and any redemption date, the average, as determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to
the Quotation Agent by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding such redemption date. 

“Treasury Rate” means, with respect to any redemption date, the rate per annum equal to the semi-annual equivalent
yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date. 

Notice of any redemption will be sent at least 30 days but not more than 60 days before the redemption date to each Holder of the Notes to be
redeemed. Unless the Issuer defaults in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes are to be redeemed, the
Notes to be redeemed shall be selected by lot by the Depositary, in the case of Notes represented by a Global Note, or by the Trustee by a method the Trustee deems to be fair and appropriate, in the case of Notes that are not represented by a Global
Note. 
 7. Defaults and Remedies. 

  
 18 

 If an Event of Default (other than certain bankruptcy Events of Default with respect to the
Issuer) under the Indenture occurs with respect to the Notes and is continuing, then the Trustee may and, at the direction of the Holders of at least 25% in principal amount of the outstanding Notes, shall by written notice, require the Issuer to
repay immediately the entire principal amount of the Outstanding Notes, together with all accrued and unpaid interest and premium, if any. If a bankruptcy Event of Default with respect to the Issuer occurs and is continuing, then the entire
principal amount of the Outstanding Notes will automatically become due immediately and payable without any declaration or other act on the part of the Trustee or any Holder. Holders of Notes may not enforce the Indenture or the Notes except as
provided in the Indenture. The Trustee is not obligated to enforce the Indenture or the Notes unless it has received indemnity as it reasonably requires. The Indenture permits, subject to certain limitations therein provided, Holders of a majority
in aggregate principal amount of the Notes then outstanding to direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of certain continuing defaults or Events of Default if it determines that
withholding notice is in their interest. 
 8. Authentication. 

This Note shall not be valid until the Trustee manually signs the certificate of authentication on this Note. 

9. Abbreviations and Defined Terms. 

Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as: TEN COM (= tenants in common), TEN ENT (=
tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

10. CUSIP Numbers. 
 Pursuant to
a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Issuer has caused CUSIP numbers to be printed on the Notes as a convenience to the Holders of the Notes. No representation is made as to the accuracy of
such numbers as printed on the Notes and reliance may be placed only on the other identification numbers printed hereon. 
 11. Governing
Law. 
 The laws of the State of New York shall govern the Indenture and this Note thereof. 

  
 19 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: 
 I or we assign
and transfer this Note to 
 (Print or type assignee’s name, address and zip code) 

(Insert assignee’s soc. sec. or tax I.D. No.) 

and irrevocably appoint                     agent to
transfer this Note on the books of the Issuer. The agent may substitute another to act for him. 
  

							
	  

				
	Date:		  
		Your Signature:		  

	
	  

	Sign exactly as your name appears on the other side of this Note.
				
							  

							Signature
			
	Signature Guarantee:				
			
	  
				  

	Signature must be guaranteed				Signature

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the
Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to,
or in substitution for, STAMP, all in accordance with the United States Securities Exchange Act of 1934, as amended. 

  
 20 

 SCHEDULE OF EXCHANGES OF NOTES 

The following exchanges of a part of this Global Note for Physical Notes or a part of another Global Note have been made: 

 

									
	 Date of Exchange
	 	 Amount of decrease in
principal amount of
this
Global Note
	 	 Amount of increase in
principal amount of
this
Global Note
	  	Principal amount of this
Global Note following
such decrease (or
increase)	  	Signature of authorized
officer of Trustee
		 		 		  		  	
		 		 		  		  	

  
 21 

 EXHIBIT B 

[FORM OF 2.950% NOTES DUE 2025] 

UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
(“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC
(AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN. 
 TRANSFERS OF THIS NOTE ARE LIMITED TO TRANSFERS IN WHOLE,
BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS OF THE INDENTURE. 

IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH
TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 

  
 22 

 ORACLE CORPORATION 

2.950% Notes due 2025 
  

			
	No.		CUSIP No.: 68389X BC8
			ISIN No.: US68389XBC83
		
			$            

 ORACLE CORPORATION, a Delaware corporation (the “Issuer”), for value received promises
to pay to CEDE & CO. or registered assigns the principal sum of                     DOLLARS on May 15, 2025. 

Interest Payment Dates: May 15 and November 15 (each, an “Interest Payment Date”), commencing on November 15,
2015. 
 Interest Record Dates: April 30 and October 31 (each, an “Interest Record Date”). 

Reference is made to the further provisions of this Note contained herein, which will for all purposes have the same effect as if set forth at
this place. 

  
 23 

 IN WITNESS WHEREOF, the Issuer has caused this Note to be signed manually or by facsimile by its
duly authorized officers. 
  

					
	ORACLE CORPORATION
		
	By:		  

			Name:		Safra A. Catz
			Title:		Chief Executive Officer
		
	By:		  

			Name:		Eric R. Ball
			Title:		Senior Vice President and Treasurer

  
 24 

 This is one of the Notes of the series designated herein and referred to in the within-mentioned
Indenture. 
 Dated: May 5, 2015 
  

			
	The Bank of New York Mellon Trust Company, N.A., as Trustee
		
	By:		  

			Authorized Signatory

  
 25 

 (REVERSE OF NOTE) 

ORACLE CORPORATION 
 2.950% Notes
due 2025 
 1. Interest 

Oracle Corporation (the “Issuer”) promises to pay interest on the principal amount of this Note at the rate per annum
described above. Cash interest on the Notes will accrue from the most recent date to which interest has been paid; or, if no interest has been paid, from May 5, 2015. Interest on this Note will be paid to but excluding the relevant Interest
Payment Date. The Issuer will pay interest semi-annually in arrears on each Interest Payment Date, commencing November 15, 2015. Interest will be computed on the basis of a 360-day year consisting of twelve 30-day months in a manner consistent
with Rule 11620(b) of the FINRA Uniform Practice Code. 
 The Issuer shall pay interest on overdue principal from time to time on
demand at the rate borne by the Notes and on overdue installments of interest (without regard to any applicable grace periods) to the extent lawful. 

2. Paying Agent. 

Initially, The Bank of New York Mellon Trust Company, N.A. (the “Trustee”) will act as paying agent. The Issuer may
change any paying agent without notice to the Holders. 
 3. Indenture; Defined Terms. 

This Note is one of the 2.950% Notes due 2025 (the “Notes”) issued under an indenture dated as of January 13,
2006 (the “Base Indenture”) by and among the Issuer (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by a supplemental indenture dated as of
May 9, 2007 (together with the Base Indenture, the “Indenture”) by and among the Issuer, Citibank, N.A. and the Trustee, and established pursuant to an Officers’ Certificate dated May 5, 2015, issued pursuant to
Section 2.01 and Section 2.03 of the Base Indenture. This Note is a “Security” and the Notes are “Securities” under the Indenture. 

For purposes of this Note, unless otherwise defined herein, capitalized terms herein are used as defined in the Indenture. The terms of
the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa-77bbbb) (the “TIA”) as in effect on the date on which the Indenture was
qualified under the TIA. Notwithstanding anything to the contrary herein, the Notes are subject to all such terms, and holders of Notes are referred to the Indenture and the TIA for a statement of them. To the extent the terms of the Indenture and
this Note are inconsistent, the terms of the Indenture shall govern. 

  
 26 

 4. Denominations; Transfer; Exchange. 

The Notes are in registered form, without coupons, in denominations of $2,000 and multiples of $1,000 thereafter. A Holder shall register the
transfer or exchange of Notes in accordance with the Indenture. The Issuer may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay certain transfer taxes or similar governmental charges payable
in connection therewith as permitted by the Indenture. The Issuer need not issue, authenticate, register the transfer of or exchange any Notes or portions thereof for a period of fifteen (15) days before the sending of a notice of redemption,
nor need the Issuer register the transfer or exchange of any Note selected for redemption in whole or in part. 
 5. Amendment; Supplement;
Waiver. 
 Subject to certain exceptions, the Notes and the provisions of the Indenture relating to the Notes may be amended or supplemented
and any existing default or Event of Default or compliance with certain provisions may be waived with the written consent of the Holders of at least a majority in aggregate principal amount of all series of Outstanding Securities (including the
Notes) under the Indenture that are affected by such amendment, supplement or waiver (voting as a single class). Without notice to or consent of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other
things, cure any ambiguity, defect or inconsistency or comply with any requirements of the Commission in connection with the qualification of the Indenture under the TIA, or make any other change that does not adversely affect the rights of any
Holder of a Note. 
 6. Redemption. 

The Issuer may at its option redeem any of the Notes in whole or in part at any time prior to February 15, 2025 (three months prior to
the maturity date), each at a redemption price calculated by the Issuer equal to the greater of: 
 (i) 100% of the principal amount of the
Notes to be redeemed; and 
 (ii) the sum of the present values of the remaining scheduled payments of principal and interest that would be
due but for the redemption if the Notes matured on February 15, 2025 (not including any portion of such payments of interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day
year consisting of twelve 30-day months) at the Treasury Rate (as defined below) plus 15 basis points, 
 plus in each case accrued and unpaid interest
thereon to the date of redemption. 
 At any time on or after February 15, 2025 (three months prior to the maturity date), the Notes
will be redeemable, in whole or in part, at the Issuer’s option, at a redemption price calculated by the Issuer equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest thereon to the date of
redemption. 
 Notwithstanding the foregoing, installments of interest on Notes that are due and payable on interest payment dates falling
on or prior to a redemption date will be payable on the interest payment date to the registered Holders as of the close of business on the relevant record date according to the Notes and the Indenture. 

  
 27 

 “Comparable Treasury Issue” means the United States Treasury security or
securities selected by the Quotation Agent as having an actual or interpolated maturity comparable to the remaining term of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial
practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the Notes. 

“Comparable Treasury Price” means, with respect to any redemption date, (i) the average of four Reference
Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Quotation Agent obtains fewer than four such Reference Treasury Dealer Quotations, the average
of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, such quotation. 

“Quotation Agent” means the Reference Treasury Dealer appointed by the Issuer. 

“Reference Treasury Dealer” means (i) J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith
Incorporated and a Primary Treasury Dealer (defined herein) selected by Wells Fargo Securities, LLC (or their respective affiliates that are Primary Treasury Dealers) and their respective successors; provided, however, that if
any of the foregoing shall cease to be a primary U.S. Government securities dealer in New York City (a “Primary Treasury Dealer”), the Issuer will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary
Treasury Dealer selected by the Issuer. 
 “Reference Treasury Dealer Quotations” means, with respect to each
Reference Treasury Dealer and any redemption date, the average, as determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to
the Quotation Agent by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding such redemption date. 

“Treasury Rate” means, with respect to any redemption date, the rate per annum equal to the semi-annual equivalent
yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date. 

Notice of any redemption will be sent at least 30 days but not more than 60 days before the redemption date to each Holder of the Notes to be
redeemed. Unless the Issuer defaults in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes are to be redeemed, the
Notes to be redeemed shall be selected by lot by the Depositary, in the case of Notes represented by a Global Note, or by the Trustee by a method the Trustee deems to be fair and appropriate, in the case of Notes that are not represented by a Global
Note. 
 7. Defaults and Remedies. 

  
 28 

 If an Event of Default (other than certain bankruptcy Events of Default with respect to the
Issuer) under the Indenture occurs with respect to the Notes and is continuing, then the Trustee may and, at the direction of the Holders of at least 25% in principal amount of the outstanding Notes, shall by written notice, require the Issuer to
repay immediately the entire principal amount of the Outstanding Notes, together with all accrued and unpaid interest and premium, if any. If a bankruptcy Event of Default with respect to the Issuer occurs and is continuing, then the entire
principal amount of the Outstanding Notes will automatically become due immediately and payable without any declaration or other act on the part of the Trustee or any Holder. Holders of Notes may not enforce the Indenture or the Notes except as
provided in the Indenture. The Trustee is not obligated to enforce the Indenture or the Notes unless it has received indemnity as it reasonably requires. The Indenture permits, subject to certain limitations therein provided, Holders of a majority
in aggregate principal amount of the Notes then outstanding to direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of certain continuing defaults or Events of Default if it determines that
withholding notice is in their interest. 
 8. Authentication. 

This Note shall not be valid until the Trustee manually signs the certificate of authentication on this Note. 

9. Abbreviations and Defined Terms. 

Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as: TEN COM (= tenants in common), TEN ENT (=
tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

10. CUSIP Numbers. 
 Pursuant to
a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Issuer has caused CUSIP numbers to be printed on the Notes as a convenience to the Holders of the Notes. No representation is made as to the accuracy of
such numbers as printed on the Notes and reliance may be placed only on the other identification numbers printed hereon. 
 11. Governing
Law. 
 The laws of the State of New York shall govern the Indenture and this Note thereof. 

  
 29 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: 
 I or we assign
and transfer this Note to 
 (Print or type assignee’s name, address and zip code) 

(Insert assignee’s soc. sec. or tax I.D. No.) 

and irrevocably appoint                     agent to
transfer this Note on the books of the Issuer. The agent may substitute another to act for him. 
  

							
	  

				
	Date:		  
		Your Signature:		  

	
	  

	Sign exactly as your name appears on the other side of this Note.
			
					  

					Signature
	Signature Guarantee:				
			
	  
				  

	Signature must be guaranteed				Signature

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the
Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to,
or in substitution for, STAMP, all in accordance with the United States Securities Exchange Act of 1934, as amended. 

  
 30 

 SCHEDULE OF EXCHANGES OF NOTES 

The following exchanges of a part of this Global Note for Physical Notes or a part of another Global Note have been made: 

 

									
	 Date of Exchange
	 	 Amount of decrease in
principal amount of
this
Global Note
	 	 Amount of increase in
principal amount of
this
Global Note
	  	Principal amount of this
Global Note following
such decrease (or
increase)	  	Signature of authorized
officer of Trustee
		 		 		  		  	
		 		 		  		  	

  
 31 

 EXHIBIT C 

[FORM OF 3.250% NOTES DUE 2030] 

UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
(“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC
(AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN. 
 TRANSFERS OF THIS NOTE ARE LIMITED TO TRANSFERS IN
WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS OF THE INDENTURE. 

IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH
TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 

  
 32 

 ORACLE CORPORATION 

3.250% Notes due 2030 
  

			
	No.		CUSIP No.: 68389X BD6
			ISIN No.: US68389XBD66
		
			$            

 ORACLE CORPORATION, a Delaware corporation (the “Issuer”), for value received promises
to pay to CEDE & CO. or registered assigns the principal sum of                     DOLLARS on May 15, 2030. 

Interest Payment Dates: May 15 and November 15 (each, an “Interest Payment Date”), commencing on November 15,
2015. 
 Interest Record Dates: April 30 and October 31 (each, an “Interest Record Date”). 

Reference is made to the further provisions of this Note contained herein, which will for all purposes have the same effect as if set forth at
this place. 

  
 33 

 IN WITNESS WHEREOF, the Issuer has caused this Note to be signed manually or by facsimile by its
duly authorized officers. 
  

					
	ORACLE CORPORATION
		
	By:		  

			Name:		Safra A. Catz
			Title:		Chief Executive Officer
		
	By:		  

			Name:		Eric R. Ball
			Title:		Senior Vice President and Treasurer

  
 34 

 This is one of the Notes of the series designated herein and referred to in the within-mentioned
Indenture. 
 Dated: May 5, 2015 
  

			
	The Bank of New York Mellon Trust Company, N.A., as Trustee
		
	By:		  

			Authorized Signatory

  
 35 

 (REVERSE OF NOTE) 

ORACLE CORPORATION 
 3.250% Notes
due 2030 
 1. Interest 

Oracle Corporation (the “Issuer”) promises to pay interest on the principal amount of this Note at the rate per annum
described above. Cash interest on the Notes will accrue from the most recent date to which interest has been paid; or, if no interest has been paid, from May 5, 2015. Interest on this Note will be paid to but excluding the relevant Interest
Payment Date. The Issuer will pay interest semi-annually in arrears on each Interest Payment Date, commencing November 15, 2015. Interest will be computed on the basis of a 360-day year consisting of twelve 30-day months in a manner consistent
with Rule 11620(b) of the FINRA Uniform Practice Code. 
 The Issuer shall pay interest on overdue principal from time to time on
demand at the rate borne by the Notes and on overdue installments of interest (without regard to any applicable grace periods) to the extent lawful. 

2. Paying Agent. 

Initially, The Bank of New York Mellon Trust Company, N.A. (the “Trustee”) will act as paying agent. The Issuer may
change any paying agent without notice to the Holders. 
 3. Indenture; Defined Terms. 

This Note is one of the 3.250% Notes due 2030 (the “Notes”) issued under an indenture dated as of January 13,
2006 (the “Base Indenture”) by and among the Issuer (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by a supplemental indenture dated as of
May 9, 2007 (together with the Base Indenture, the “Indenture”) by and among the Issuer, Citibank, N.A. and the Trustee, and established pursuant to an Officers’ Certificate dated April 28, 2015, issued pursuant to
Section 2.01 and Section 2.03 of the Base Indenture. This Note is a “Security” and the Notes are “Securities” under the Indenture. 

For purposes of this Note, unless otherwise defined herein, capitalized terms herein are used as defined in the Indenture. The terms of
the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa-77bbbb) (the “TIA”) as in effect on the date on which the Indenture was
qualified under the TIA. Notwithstanding anything to the contrary herein, the Notes are subject to all such terms, and holders of Notes are referred to the Indenture and the TIA for a statement of them. To the extent the terms of the Indenture and
this Note are inconsistent, the terms of the Indenture shall govern. 

  
 36 

 4. Denominations; Transfer; Exchange. 

The Notes are in registered form, without coupons, in denominations of $2,000 and multiples of $1,000 thereafter. A Holder shall register the
transfer or exchange of Notes in accordance with the Indenture. The Issuer may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay certain transfer taxes or similar governmental charges payable
in connection therewith as permitted by the Indenture. The Issuer need not issue, authenticate, register the transfer of or exchange any Notes or portions thereof for a period of fifteen (15) days before the sending of a notice of redemption,
nor need the Issuer register the transfer or exchange of any Note selected for redemption in whole or in part. 
 5. Amendment; Supplement;
Waiver. 
 Subject to certain exceptions, the Notes and the provisions of the Indenture relating to the Notes may be amended or supplemented
and any existing default or Event of Default or compliance with certain provisions may be waived with the written consent of the Holders of at least a majority in aggregate principal amount of all series of Outstanding Securities (including the
Notes) under the Indenture that are affected by such amendment, supplement or waiver (voting as a single class). Without notice to or consent of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other
things, cure any ambiguity, defect or inconsistency or comply with any requirements of the Commission in connection with the qualification of the Indenture under the TIA, or make any other change that does not adversely affect the rights of any
Holder of a Note. 
 6. Redemption. 

The Issuer may at its option redeem any of the Notes in whole or in part at any time prior to February 15, 2030 (three months prior to
the maturity date), each at a redemption price calculated by the Issuer equal to the greater of: 
 (i) 100% of the principal amount of the
Notes to be redeemed; and 
 (ii) the sum of the present values of the remaining scheduled payments of principal and interest that would be
due but for the redemption if the Notes matured on February 15, 2030 (not including any portion of such payments of interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day
year consisting of twelve 30-day months) at the Treasury Rate (as defined below) plus 20 basis points, 
 plus in each case accrued and unpaid interest
thereon to the date of redemption. 
 At any time on or after February 15, 2030 (three months prior to the maturity date), the Notes
will be redeemable, in whole or in part, at the Issuer’s option, at a redemption price calculated by the Issuer equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest thereon to the date of
redemption. 
 Notwithstanding the foregoing, installments of interest on Notes that are due and payable on interest payment dates falling
on or prior to a redemption date will be payable on the interest payment date to the registered Holders as of the close of business on the relevant record date according to the Notes and the Indenture. 

  
 37 

 “Comparable Treasury Issue” means the United States Treasury security or
securities selected by the Quotation Agent as having an actual or interpolated maturity comparable to the remaining term of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial
practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the Notes. 

“Comparable Treasury Price” means, with respect to any redemption date, (i) the average of four Reference
Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Quotation Agent obtains fewer than four such Reference Treasury Dealer Quotations, the average
of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, such quotation. 

“Quotation Agent” means the Reference Treasury Dealer appointed by the Issuer. 

“Reference Treasury Dealer” means (i) J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith
Incorporated and a Primary Treasury Dealer (defined herein) selected by Wells Fargo Securities, LLC (or their respective affiliates that are Primary Treasury Dealers) and their respective successors; provided, however, that if
any of the foregoing shall cease to be a primary U.S. Government securities dealer in New York City (a “Primary Treasury Dealer”), the Issuer will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary
Treasury Dealer selected by the Issuer. 
 “Reference Treasury Dealer Quotations” means, with respect to each
Reference Treasury Dealer and any redemption date, the average, as determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to
the Quotation Agent by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding such redemption date. 

“Treasury Rate” means, with respect to any redemption date, the rate per annum equal to the semi-annual equivalent
yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date. 

Notice of any redemption will be sent at least 30 days but not more than 60 days before the redemption date to each Holder of the Notes to be
redeemed. Unless the Issuer defaults in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes are to be redeemed, the
Notes to be redeemed shall be selected by lot by the Depositary, in the case of Notes represented by a Global Note, or by the Trustee by a method the Trustee deems to be fair and appropriate, in the case of Notes that are not represented by a Global
Note. 
 7. Defaults and Remedies. 

  
 38 

 If an Event of Default (other than certain bankruptcy Events of Default with respect to the
Issuer) under the Indenture occurs with respect to the Notes and is continuing, then the Trustee may and, at the direction of the Holders of at least 25% in principal amount of the outstanding Notes, shall by written notice, require the Issuer to
repay immediately the entire principal amount of the Outstanding Notes, together with all accrued and unpaid interest and premium, if any. If a bankruptcy Event of Default with respect to the Issuer occurs and is continuing, then the entire
principal amount of the Outstanding Notes will automatically become due immediately and payable without any declaration or other act on the part of the Trustee or any Holder. Holders of Notes may not enforce the Indenture or the Notes except as
provided in the Indenture. The Trustee is not obligated to enforce the Indenture or the Notes unless it has received indemnity as it reasonably requires. The Indenture permits, subject to certain limitations therein provided, Holders of a majority
in aggregate principal amount of the Notes then outstanding to direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of certain continuing defaults or Events of Default if it determines that
withholding notice is in their interest. 
 8. Authentication. 

This Note shall not be valid until the Trustee manually signs the certificate of authentication on this Note. 

9. Abbreviations and Defined Terms. 

Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as: TEN COM (= tenants in common), TEN ENT (=
tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

10. CUSIP Numbers. 
 Pursuant to
a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Issuer has caused CUSIP numbers to be printed on the Notes as a convenience to the Holders of the Notes. No representation is made as to the accuracy of
such numbers as printed on the Notes and reliance may be placed only on the other identification numbers printed hereon. 
 11. Governing
Law. 
 The laws of the State of New York shall govern the Indenture and this Note thereof. 

  
 39 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: 
 I or we assign
and transfer this Note to 
 (Print or type assignee’s name, address and zip code) 

(Insert assignee’s soc. sec. or tax I.D. No.) 

and irrevocably appoint                     agent to
transfer this Note on the books of the Issuer. The agent may substitute another to act for him. 
  

							
	  

				
	Date:		  
		Your Signature:		  

	
	  

	Sign exactly as your name appears on the other side of this Note.
			
					  

					Signature
	Signature Guarantee:				
			
	  
				  

	Signature must be guaranteed				Signature

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the
Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to,
or in substitution for, STAMP, all in accordance with the United States Securities Exchange Act of 1934, as amended. 

  
 40 

 SCHEDULE OF EXCHANGES OF NOTES 

The following exchanges of a part of this Global Note for Physical Notes or a part of another Global Note have been made: 

 

									
	 Date of Exchange
	 	 Amount of decrease in
principal amount of
this
Global Note
	 	 Amount of increase in
principal amount of
this
Global Note
	  	Principal amount of this
Global Note following
such decrease (or
increase)	  	Signature of authorized
officer of Trustee
		 		 		  		  	
		 		 		  		  	

  
 41 

 EXHIBIT D 

[FORM OF 3.900% NOTES DUE 2035] 

UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
(“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC
(AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN. 
 TRANSFERS OF THIS NOTE ARE LIMITED TO TRANSFERS IN
WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS OF THE INDENTURE. 

IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH
TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 

  
 42 

 ORACLE CORPORATION 

3.900% Notes due 2035 
  

			
	No.		CUSIP No.: 68389X BE4
			ISIN No.: US68389XBE40
		
			$            

 ORACLE CORPORATION, a Delaware corporation (the “Issuer”), for value received promises
to pay to CEDE & CO. or registered assigns the principal sum of                     DOLLARS on May 15, 2035. 

Interest Payment Dates: May 15 and November 15 (each, an “Interest Payment Date”), commencing on November 15,
2015. 
 Interest Record Dates: April 30 and October 31 (each, an “Interest Record Date”). 

Reference is made to the further provisions of this Note contained herein, which will for all purposes have the same effect as if set forth at
this place. 

  
 43 

 IN WITNESS WHEREOF, the Issuer has caused this Note to be signed manually or by facsimile by its
duly authorized officers. 
  

					
	ORACLE CORPORATION
		
	By:		  

			Name:		Safra A. Catz
			Title:		Chief Executive Officer
		
	By:		  

			Name:		Eric R. Ball
			Title:		Senior Vice President and Treasurer

  
 44 

 This is one of the Notes of the series designated herein and referred to in the within-mentioned
Indenture. 
 Dated: May 5, 2015 
  

			
	The Bank of New York Mellon Trust Company, N.A., as Trustee
		
	By:		  

			Authorized Signatory

  
 45 

 (REVERSE OF NOTE) 

ORACLE CORPORATION 
 3.900% Notes
due 2035 
 1. Interest 

Oracle Corporation (the “Issuer”) promises to pay interest on the principal amount of this Note at the rate per annum
described above. Cash interest on the Notes will accrue from the most recent date to which interest has been paid; or, if no interest has been paid, from May 5, 2015. Interest on this Note will be paid to but excluding the relevant Interest
Payment Date. The Issuer will pay interest semi-annually in arrears on each Interest Payment Date, commencing November 15, 2015. Interest will be computed on the basis of a 360-day year consisting of twelve 30-day months in a manner consistent
with Rule 11620(b) of the FINRA Uniform Practice Code. 
 The Issuer shall pay interest on overdue principal from time to time on
demand at the rate borne by the Notes and on overdue installments of interest (without regard to any applicable grace periods) to the extent lawful. 

2. Paying Agent. 

Initially, The Bank of New York Mellon Trust Company, N.A. (the “Trustee”) will act as paying agent. The Issuer may
change any paying agent without notice to the Holders. 
 3. Indenture; Defined Terms. 

This Note is one of the 3.900% Notes due 2035 (the “Notes”) issued under an indenture dated as of January 13,
2006 (the “Base Indenture”) by and among the Issuer (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by a supplemental indenture dated as of
May 9, 2007 (together with the Base Indenture, the “Indenture”) by and among the Issuer, Citibank, N.A. and the Trustee, and established pursuant to an Officers’ Certificate dated April 28, 2015, issued pursuant to
Section 2.01 and Section 2.03 of the Base Indenture. This Note is a “Security” and the Notes are “Securities” under the Indenture. 

For purposes of this Note, unless otherwise defined herein, capitalized terms herein are used as defined in the Indenture. The terms of
the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa-77bbbb) (the “TIA”) as in effect on the date on which the Indenture was
qualified under the TIA. Notwithstanding anything to the contrary herein, the Notes are subject to all such terms, and holders of Notes are referred to the Indenture and the TIA for a statement of them. To the extent the terms of the Indenture and
this Note are inconsistent, the terms of the Indenture shall govern. 

  
 46 

 4. Denominations; Transfer; Exchange. 

The Notes are in registered form, without coupons, in denominations of $2,000 and multiples of $1,000 thereafter. A Holder shall register the
transfer or exchange of Notes in accordance with the Indenture. The Issuer may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay certain transfer taxes or similar governmental charges payable
in connection therewith as permitted by the Indenture. The Issuer need not issue, authenticate, register the transfer of or exchange any Notes or portions thereof for a period of fifteen (15) days before the sending of a notice of redemption,
nor need the Issuer register the transfer or exchange of any Note selected for redemption in whole or in part. 
 5. Amendment; Supplement;
Waiver. 
 Subject to certain exceptions, the Notes and the provisions of the Indenture relating to the Notes may be amended or supplemented
and any existing default or Event of Default or compliance with certain provisions may be waived with the written consent of the Holders of at least a majority in aggregate principal amount of all series of Outstanding Securities (including the
Notes) under the Indenture that are affected by such amendment, supplement or waiver (voting as a single class). Without notice to or consent of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other
things, cure any ambiguity, defect or inconsistency or comply with any requirements of the Commission in connection with the qualification of the Indenture under the TIA, or make any other change that does not adversely affect the rights of any
Holder of a Note. 
 6. Redemption. 

The Issuer may at its option redeem any of the Notes in whole or in part at any time prior to November 15, 2034 (six months prior to the
maturity date), each at a redemption price calculated by the Issuer equal to the greater of: 
 (i) 100% of the principal amount of the
Notes to be redeemed; and 
 (ii) the sum of the present values of the remaining scheduled payments of principal and interest that would be
due but for the redemption if the Notes matured on November 15, 2034 (not including any portion of such payments of interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day
year consisting of twelve 30-day months) at the Treasury Rate (as defined below) plus 20 basis points, 
 plus in each case accrued and unpaid interest
thereon to the date of redemption. 
 At any time on or after November 15, 2034 (six months prior to the maturity date), the Notes will
be redeemable, in whole or in part, at the Issuer’s option, at a redemption price calculated by the Issuer equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest thereon to the date of redemption.

 Notwithstanding the foregoing, installments of interest on Notes that are due and payable on interest payment dates falling on or prior
to a redemption date will be payable on the interest payment date to the registered Holders as of the close of business on the relevant record date according to the Notes and the Indenture. 

  
 47 

 “Comparable Treasury Issue” means the United States Treasury security or
securities selected by the Quotation Agent as having an actual or interpolated maturity comparable to the remaining term of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial
practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the Notes. 

“Comparable Treasury Price” means, with respect to any redemption date, (i) the average of four Reference
Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Quotation Agent obtains fewer than four such Reference Treasury Dealer Quotations, the average
of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, such quotation. 

“Quotation Agent” means the Reference Treasury Dealer appointed by the Issuer. 

“Reference Treasury Dealer” means (i) J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith
Incorporated and a Primary Treasury Dealer (defined herein) selected by Wells Fargo Securities, LLC (or their respective affiliates that are Primary Treasury Dealers) and their respective successors; provided, however, that if
any of the foregoing shall cease to be a primary U.S. Government securities dealer in New York City (a “Primary Treasury Dealer”), the Issuer will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary
Treasury Dealer selected by the Issuer. 
 “Reference Treasury Dealer Quotations” means, with respect to each
Reference Treasury Dealer and any redemption date, the average, as determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to
the Quotation Agent by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding such redemption date. 

“Treasury Rate” means, with respect to any redemption date, the rate per annum equal to the semi-annual equivalent
yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date. 

Notice of any redemption will be sent at least 30 days but not more than 60 days before the redemption date to each Holder of the Notes to be
redeemed. Unless the Issuer defaults in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes are to be redeemed, the
Notes to be redeemed shall be selected by lot by the Depositary, in the case of Notes represented by a Global Note, or by the Trustee by a method the Trustee deems to be fair and appropriate, in the case of Notes that are not represented by a Global
Note. 
 7. Defaults and Remedies. 

  
 48 

 If an Event of Default (other than certain bankruptcy Events of Default with respect to the
Issuer) under the Indenture occurs with respect to the Notes and is continuing, then the Trustee may and, at the direction of the Holders of at least 25% in principal amount of the outstanding Notes, shall by written notice, require the Issuer to
repay immediately the entire principal amount of the Outstanding Notes, together with all accrued and unpaid interest and premium, if any. If a bankruptcy Event of Default with respect to the Issuer occurs and is continuing, then the entire
principal amount of the Outstanding Notes will automatically become due immediately and payable without any declaration or other act on the part of the Trustee or any Holder. Holders of Notes may not enforce the Indenture or the Notes except as
provided in the Indenture. The Trustee is not obligated to enforce the Indenture or the Notes unless it has received indemnity as it reasonably requires. The Indenture permits, subject to certain limitations therein provided, Holders of a majority
in aggregate principal amount of the Notes then outstanding to direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of certain continuing defaults or Events of Default if it determines that
withholding notice is in their interest. 
 8. Authentication. 

This Note shall not be valid until the Trustee manually signs the certificate of authentication on this Note. 

9. Abbreviations and Defined Terms. 

Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as: TEN COM (= tenants in common), TEN ENT (=
tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

10. CUSIP Numbers. 
 Pursuant to
a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Issuer has caused CUSIP numbers to be printed on the Notes as a convenience to the Holders of the Notes. No representation is made as to the accuracy of
such numbers as printed on the Notes and reliance may be placed only on the other identification numbers printed hereon. 
 11. Governing
Law. 
 The laws of the State of New York shall govern the Indenture and this Note thereof. 

  
 49 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: 
 I or we assign
and transfer this Note to 
 (Print or type assignee’s name, address and zip code) 

(Insert assignee’s soc. sec. or tax I.D. No.) 

and irrevocably appoint                     agent to
transfer this Note on the books of the Issuer. The agent may substitute another to act for him. 
  

							
	  

				
	Date:		  
		Your Signature:		  

	
	  

	Sign exactly as your name appears on the other side of this Note.
							  

							Signature
			
	Signature Guarantee:				
			
	  
				  

	Signature must be guaranteed				Signature

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the
Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to,
or in substitution for, STAMP, all in accordance with the United States Securities Exchange Act of 1934, as amended. 

  
 50 

 SCHEDULE OF EXCHANGES OF NOTES 

The following exchanges of a part of this Global Note for Physical Notes or a part of another Global Note have been made: 

 

									
	 Date of Exchange
	 	 Amount of decrease in
principal amount of
this
Global Note
	 	 Amount of increase in
principal amount of
this
Global Note
	  	Principal amount of this
Global Note following
such decrease (or
increase)	  	Signature of authorized
officer of Trustee
		 		 		  		  	
		 		 		  		  	

  
 51 

 EXHIBIT E 

[FORM OF 4.125% NOTES DUE 2045] 

UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
(“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC
(AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN. 
 TRANSFERS OF THIS NOTE ARE LIMITED TO TRANSFERS IN
WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS OF THE INDENTURE. 

IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH
TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 

  
 52 

 ORACLE CORPORATION 

4.125% Notes due 2045 
  

			
	No.		CUSIP No.: 68389X BF1
			ISIN No.: US68389XBF15
		
			$            

 ORACLE CORPORATION, a Delaware corporation (the “Issuer”), for value received promises
to pay to CEDE & CO. or registered assigns the principal sum of                     DOLLARS on May 15, 2045. 

Interest Payment Dates: May 15 and November 15 (each, an “Interest Payment Date”), commencing on November 15,
2015. 
 Interest Record Dates: April 30 and October 31 (each, an “Interest Record Date”). 

Reference is made to the further provisions of this Note contained herein, which will for all purposes have the same effect as if set forth at
this place. 

  
 53 

 IN WITNESS WHEREOF, the Issuer has caused this Note to be signed manually or by facsimile by its
duly authorized officers. 
  

					
	ORACLE CORPORATION
		
	By:		  

			Name:		Safra A. Catz
			Title:		Chief Executive Officer
		
	By:		  

			Name:		Eric R. Ball
			Title:		Senior Vice President and Treasurer

  
 54 

 This is one of the Notes of the series designated herein and referred to in the within-mentioned
Indenture. 
 Dated: May 5, 2015 
  

			
	The Bank of New York Mellon Trust Company, N.A., as Trustee
		
	By:		  

			Authorized Signatory

  
 55 

 (REVERSE OF NOTE) 

ORACLE CORPORATION 
 4.125% Notes
due 2045 
 1. Interest 

Oracle Corporation (the “Issuer”) promises to pay interest on the principal amount of this Note at the rate per annum
described above. Cash interest on the Notes will accrue from the most recent date to which interest has been paid; or, if no interest has been paid, from May 5, 2015. Interest on this Note will be paid to but excluding the relevant Interest
Payment Date. The Issuer will pay interest semi-annually in arrears on each Interest Payment Date, commencing November 15, 2015. Interest will be computed on the basis of a 360-day year consisting of twelve 30-day months in a manner consistent
with Rule 11620(b) of the FINRA Uniform Practice Code. 
 The Issuer shall pay interest on overdue principal from time to time on
demand at the rate borne by the Notes and on overdue installments of interest (without regard to any applicable grace periods) to the extent lawful. 

2. Paying Agent. 

Initially, The Bank of New York Mellon Trust Company, N.A. (the “Trustee”) will act as paying agent. The Issuer may
change any paying agent without notice to the Holders. 
 3. Indenture; Defined Terms. 

This Note is one of the 4.125% Notes due 2045 (the “Notes”) issued under an indenture dated as of January 13,
2006 (the “Base Indenture”) by and among the Issuer (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by a supplemental indenture dated as of
May 9, 2007 (together with the Base Indenture, the “Indenture”) by and among the Issuer, Citibank, N.A. and the Trustee, and established pursuant to an Officers’ Certificate dated April 28, 2015, issued pursuant to
Section 2.01 and Section 2.03 of the Base Indenture. This Note is a “Security” and the Notes are “Securities” under the Indenture. 

For purposes of this Note, unless otherwise defined herein, capitalized terms herein are used as defined in the Indenture. The terms of
the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa-77bbbb) (the “TIA”) as in effect on the date on which the Indenture was
qualified under the TIA. Notwithstanding anything to the contrary herein, the Notes are subject to all such terms, and holders of Notes are referred to the Indenture and the TIA for a statement of them. To the extent the terms of the Indenture and
this Note are inconsistent, the terms of the Indenture shall govern. 

  
 56 

 4. Denominations; Transfer; Exchange. 

The Notes are in registered form, without coupons, in denominations of $2,000 and multiples of $1,000 thereafter. A Holder shall register the
transfer or exchange of Notes in accordance with the Indenture. The Issuer may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay certain transfer taxes or similar governmental charges payable
in connection therewith as permitted by the Indenture. The Issuer need not issue, authenticate, register the transfer of or exchange any Notes or portions thereof for a period of fifteen (15) days before the sending of a notice of redemption,
nor need the Issuer register the transfer or exchange of any Note selected for redemption in whole or in part. 
 5. Amendment; Supplement;
Waiver. 
 Subject to certain exceptions, the Notes and the provisions of the Indenture relating to the Notes may be amended or supplemented
and any existing default or Event of Default or compliance with certain provisions may be waived with the written consent of the Holders of at least a majority in aggregate principal amount of all series of Outstanding Securities (including the
Notes) under the Indenture that are affected by such amendment, supplement or waiver (voting as a single class). Without notice to or consent of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other
things, cure any ambiguity, defect or inconsistency or comply with any requirements of the Commission in connection with the qualification of the Indenture under the TIA, or make any other change that does not adversely affect the rights of any
Holder of a Note. 
 6. Redemption. 

The Issuer may at its option redeem any of the Notes in whole or in part at any time prior to November 15, 2044 (six months prior to the
maturity date), each at a redemption price calculated by the Issuer equal to the greater of: 
 (i) 100% of the principal amount of the
Notes to be redeemed; and 
 (ii) the sum of the present values of the remaining scheduled payments of principal and interest that would be
due but for the redemption if the Notes matured on November 15, 2044 (not including any portion of such payments of interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day
year consisting of twelve 30-day months) at the Treasury Rate (as defined below) plus 25 basis points, 
 plus in each case accrued and unpaid interest
thereon to the date of redemption. 
 At any time on or after November 15, 2044 (six months prior to the maturity date), the Notes will
be redeemable, in whole or in part, at the Issuer’s option, at a redemption price calculated by the Issuer equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest thereon to the date of redemption.

 Notwithstanding the foregoing, installments of interest on Notes that are due and payable on interest payment dates falling on or prior
to a redemption date will be payable on the interest payment date to the registered Holders as of the close of business on the relevant record date according to the Notes and the Indenture. 

  
 57 

 “Comparable Treasury Issue” means the United States Treasury security or
securities selected by the Quotation Agent as having an actual or interpolated maturity comparable to the remaining term of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial
practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the Notes. 

“Comparable Treasury Price” means, with respect to any redemption date, (i) the average of four Reference
Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Quotation Agent obtains fewer than four such Reference Treasury Dealer Quotations, the average
of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, such quotation. 

“Quotation Agent” means the Reference Treasury Dealer appointed by the Issuer. 

“Reference Treasury Dealer” means (i) J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith
Incorporated and a Primary Treasury Dealer (defined herein) selected by Wells Fargo Securities, LLC (or their respective affiliates that are Primary Treasury Dealers) and their respective successors; provided, however, that if
any of the foregoing shall cease to be a primary U.S. Government securities dealer in New York City (a “Primary Treasury Dealer”), the Issuer will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary
Treasury Dealer selected by the Issuer.  
 “Reference Treasury Dealer Quotations” means, with respect to
each Reference Treasury Dealer and any redemption date, the average, as determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in
writing to the Quotation Agent by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding such redemption date. 

“Treasury Rate” means, with respect to any redemption date, the rate per annum equal to the semi-annual equivalent
yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date. 

Notice of any redemption will be sent at least 30 days but not more than 60 days before the redemption date to each Holder of the Notes to be
redeemed. Unless the Issuer defaults in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes are to be redeemed, the
Notes to be redeemed shall be selected by lot by the Depositary, in the case of Notes represented by a Global Note, or by the Trustee by a method the Trustee deems to be fair and appropriate, in the case of Notes that are not represented by a Global
Note. 
 7. Defaults and Remedies. 

  
 58 

 If an Event of Default (other than certain bankruptcy Events of Default with respect to the
Issuer) under the Indenture occurs with respect to the Notes and is continuing, then the Trustee may and, at the direction of the Holders of at least 25% in principal amount of the outstanding Notes, shall by written notice, require the Issuer to
repay immediately the entire principal amount of the Outstanding Notes, together with all accrued and unpaid interest and premium, if any. If a bankruptcy Event of Default with respect to the Issuer occurs and is continuing, then the entire
principal amount of the Outstanding Notes will automatically become due immediately and payable without any declaration or other act on the part of the Trustee or any Holder. Holders of Notes may not enforce the Indenture or the Notes except as
provided in the Indenture. The Trustee is not obligated to enforce the Indenture or the Notes unless it has received indemnity as it reasonably requires. The Indenture permits, subject to certain limitations therein provided, Holders of a majority
in aggregate principal amount of the Notes then outstanding to direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of certain continuing defaults or Events of Default if it determines that
withholding notice is in their interest. 
 8. Authentication. 

This Note shall not be valid until the Trustee manually signs the certificate of authentication on this Note. 

9. Abbreviations and Defined Terms. 

Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as: TEN COM (= tenants in common), TEN ENT (=
tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

10. CUSIP Numbers. 
 Pursuant to
a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Issuer has caused CUSIP numbers to be printed on the Notes as a convenience to the Holders of the Notes. No representation is made as to the accuracy of
such numbers as printed on the Notes and reliance may be placed only on the other identification numbers printed hereon. 
 11. Governing
Law. 
 The laws of the State of New York shall govern the Indenture and this Note thereof. 

  
 59 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: 
 I or we assign
and transfer this Note to 
 (Print or type assignee’s name, address and zip code) 

(Insert assignee’s soc. sec. or tax I.D. No.) 

and irrevocably appoint                     agent to
transfer this Note on the books of the Issuer. The agent may substitute another to act for him. 
  

							
	  

				
	Date:		  
		Your Signature:		  

	
	  

	Sign exactly as your name appears on the other side of this Note.
					  

					Signature
			
	Signature Guarantee:				
			
	  
				  

	Signature must be guaranteed				Signature

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements
of the Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in
addition to, or in substitution for, STAMP, all in accordance with the United States Securities Exchange Act of 1934, as amended. 

  
 60 

 SCHEDULE OF EXCHANGES OF NOTES 

The following exchanges of a part of this Global Note for Physical Notes or a part of another Global Note have been made: 

 

									
	 Date of Exchange
	 	 Amount of decrease in
principal amount of
this
Global Note
	 	 Amount of increase in
principal amount of
this
Global Note
	  	Principal amount of this
Global Note following
such decrease (or
increase)	  	Signature of authorized
officer of Trustee
		 		 		  		  	
		 		 		  		  	

  
 61 

 EXHIBIT F 

[FORM OF 4.375% NOTES DUE 2055] 

UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
(“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC
(AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS A BENEFICIAL INTEREST HEREIN. 
 TRANSFERS OF THIS NOTE ARE LIMITED TO TRANSFERS IN
WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE ARE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE TRANSFER PROVISIONS OF THE INDENTURE. 

IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH
TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 

  
 62 

 ORACLE CORPORATION 

4.375% Notes due 2055 
  

			
	No.		CUSIP No.: 68389X BG9
			ISIN No.: US68389XBG97
		
			$            

 ORACLE CORPORATION, a Delaware corporation (the “Issuer”), for value received promises
to pay to CEDE & CO. or registered assigns the principal sum of                     DOLLARS on May 15, 2055. 

Interest Payment Dates: May 15 and November 15 (each, an “Interest Payment Date”), commencing on November 15,
2015. 
 Interest Record Dates: April 30 and October 31 (each, an “Interest Record Date”). 

Reference is made to the further provisions of this Note contained herein, which will for all purposes have the same effect as if set forth at
this place. 

  
 63 

 IN WITNESS WHEREOF, the Issuer has caused this Note to be signed manually or by facsimile by its
duly authorized officers. 
  

					
	ORACLE CORPORATION
		
	By:		  

			Name:		Safra A. Catz
			Title:		Chief Executive Officer
		
	By:		  

			Name:		Eric R. Ball
			Title:		Senior Vice President and Treasurer

  
 64 

 This is one of the Notes of the series designated herein and referred to in the within-mentioned
Indenture. 
 Dated: May 5, 2015 
  

			
	The Bank of New York Mellon Trust Company, N.A., as Trustee
		
	By:		  

			Authorized Signatory

  
 65 

 (REVERSE OF NOTE) 

ORACLE CORPORATION 
 4.375% Notes
due 2055 
 1. Interest 

Oracle Corporation (the “Issuer”) promises to pay interest on the principal amount of this Note at the rate per annum
described above. Cash interest on the Notes will accrue from the most recent date to which interest has been paid; or, if no interest has been paid, from May 5, 2015. Interest on this Note will be paid to but excluding the relevant Interest
Payment Date. The Issuer will pay interest semi-annually in arrears on each Interest Payment Date, commencing November 15, 2015. Interest will be computed on the basis of a 360-day year consisting of twelve 30-day months in a manner consistent
with Rule 11620(b) of the FINRA Uniform Practice Code. 
 The Issuer shall pay interest on overdue principal from time to time on
demand at the rate borne by the Notes and on overdue installments of interest (without regard to any applicable grace periods) to the extent lawful. 

2. Paying Agent. 

Initially, The Bank of New York Mellon Trust Company, N.A. (the “Trustee”) will act as paying agent. The Issuer may
change any paying agent without notice to the Holders. 
 3. Indenture; Defined Terms. 

This Note is one of the 4.375% Notes due 2055 (the “Notes”) issued under an indenture dated as of January 13,
2006 (the “Base Indenture”) by and among the Issuer (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by a supplemental indenture dated as of
May 9, 2007 (together with the Base Indenture, the “Indenture”) by and among the Issuer, Citibank, N.A. and the Trustee, and established pursuant to an Officers’ Certificate dated May 5, 2015, issued pursuant to
Section 2.01 and Section 2.03 of the Base Indenture. This Note is a “Security” and the Notes are “Securities” under the Indenture. 

For purposes of this Note, unless otherwise defined herein, capitalized terms herein are used as defined in the Indenture. The terms of
the Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa-77bbbb) (the “TIA”) as in effect on the date on which the Indenture was
qualified under the TIA. Notwithstanding anything to the contrary herein, the Notes are subject to all such terms, and holders of Notes are referred to the Indenture and the TIA for a statement of them. To the extent the terms of the Indenture and
this Note are inconsistent, the terms of the Indenture shall govern. 

  
 66 

 4. Denominations; Transfer; Exchange. 

The Notes are in registered form, without coupons, in denominations of $2,000 and multiples of $1,000 thereafter. A Holder shall register the
transfer or exchange of Notes in accordance with the Indenture. The Issuer may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay certain transfer taxes or similar governmental charges payable
in connection therewith as permitted by the Indenture. The Issuer need not issue, authenticate, register the transfer of or exchange any Notes or portions thereof for a period of fifteen (15) days before the sending of a notice of redemption,
nor need the Issuer register the transfer or exchange of any Note selected for redemption in whole or in part. 
 5. Amendment; Supplement;
Waiver. 
 Subject to certain exceptions, the Notes and the provisions of the Indenture relating to the Notes may be amended or supplemented
and any existing default or Event of Default or compliance with certain provisions may be waived with the written consent of the Holders of at least a majority in aggregate principal amount of all series of Outstanding Securities (including the
Notes) under the Indenture that are affected by such amendment, supplement or waiver (voting as a single class). Without notice to or consent of any Holder, the parties thereto may amend or supplement the Indenture and the Notes to, among other
things, cure any ambiguity, defect or inconsistency or comply with any requirements of the Commission in connection with the qualification of the Indenture under the TIA, or make any other change that does not adversely affect the rights of any
Holder of a Note. 
 6. Redemption. 

The Issuer may at its option redeem any of the Notes in whole or in part at any time prior to November 15, 2054 (six months prior to the
maturity date), each at a redemption price calculated by the Issuer equal to the greater of: 
 (i) 100% of the principal amount of the
Notes to be redeemed; and 
 (ii) the sum of the present values of the remaining scheduled payments of principal and interest that would be
due but for the redemption if the Notes matured on November 15, 2054 (not including any portion of such payments of interest accrued as of the date of redemption), discounted to the date of redemption on a semi-annual basis (assuming a 360-day
year consisting of twelve 30-day months) at the Treasury Rate (as defined below) plus 30 basis points, 
 plus in each case accrued and unpaid interest
thereon to the date of redemption. 
 At any time on or after November 15, 2054 (six months prior to the maturity date), the Notes will
be redeemable, in whole or in part, at the Issuer’s option, at a redemption price calculated by the Issuer equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest thereon to the date of redemption.

 Notwithstanding the foregoing, installments of interest on Notes that are due and payable on interest payment dates falling on or prior
to a redemption date will be payable on the interest payment date to the registered Holders as of the close of business on the relevant record date according to the Notes and the Indenture. 

  
 67 

 “Comparable Treasury Issue” means the United States Treasury security or
securities selected by the Quotation Agent as having an actual or interpolated maturity comparable to the remaining term of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial
practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of the Notes. 

“Comparable Treasury Price” means, with respect to any redemption date, (i) the average of four Reference
Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, or (ii) if the Quotation Agent obtains fewer than four such Reference Treasury Dealer Quotations, the average
of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, such quotation. 

“Quotation Agent” means the Reference Treasury Dealer appointed by the Issuer. 

“Reference Treasury Dealer” means (i) J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith
Incorporated and a Primary Treasury Dealer (defined herein) selected by Wells Fargo Securities, LLC (or their respective affiliates that are Primary Treasury Dealers) and their respective successors; provided, however, that if
any of the foregoing shall cease to be a primary U.S. Government securities dealer in New York City (a “Primary Treasury Dealer”), the Issuer will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary
Treasury Dealer selected by the Issuer. 
 “Reference Treasury Dealer Quotations” means, with respect to each
Reference Treasury Dealer and any redemption date, the average, as determined by the Quotation Agent, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to
the Quotation Agent by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding such redemption date. 

“Treasury Rate” means, with respect to any redemption date, the rate per annum equal to the semi-annual equivalent
yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date. 

Notice of any redemption will be sent at least 30 days but not more than 60 days before the redemption date to each Holder of the Notes to be
redeemed. Unless the Issuer defaults in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes are to be redeemed, the
Notes to be redeemed shall be selected by lot by the Depositary, in the case of Notes represented by a Global Note, or by the Trustee by a method the Trustee deems to be fair and appropriate, in the case of Notes that are not represented by a Global
Note. 
 7. Defaults and Remedies. 

  
 68 

 If an Event of Default (other than certain bankruptcy Events of Default with respect to the
Issuer) under the Indenture occurs with respect to the Notes and is continuing, then the Trustee may and, at the direction of the Holders of at least 25% in principal amount of the outstanding Notes, shall by written notice, require the Issuer to
repay immediately the entire principal amount of the Outstanding Notes, together with all accrued and unpaid interest and premium, if any. If a bankruptcy Event of Default with respect to the Issuer occurs and is continuing, then the entire
principal amount of the Outstanding Notes will automatically become due immediately and payable without any declaration or other act on the part of the Trustee or any Holder. Holders of Notes may not enforce the Indenture or the Notes except as
provided in the Indenture. The Trustee is not obligated to enforce the Indenture or the Notes unless it has received indemnity as it reasonably requires. The Indenture permits, subject to certain limitations therein provided, Holders of a majority
in aggregate principal amount of the Notes then outstanding to direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of Notes notice of certain continuing defaults or Events of Default if it determines that
withholding notice is in their interest. 
 8. Authentication. 

This Note shall not be valid until the Trustee manually signs the certificate of authentication on this Note. 

9. Abbreviations and Defined Terms. 

Customary abbreviations may be used in the name of a Holder of a Note or an assignee, such as: TEN COM (= tenants in common), TEN ENT (=
tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

10. CUSIP Numbers. 
 Pursuant to
a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Issuer has caused CUSIP numbers to be printed on the Notes as a convenience to the Holders of the Notes. No representation is made as to the accuracy of
such numbers as printed on the Notes and reliance may be placed only on the other identification numbers printed hereon. 
 11. Governing
Law. 
 The laws of the State of New York shall govern the Indenture and this Note thereof. 

  
 69 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: 
 I or we assign
and transfer this Note to 
 (Print or type assignee’s name, address and zip code) 

(Insert assignee’s soc. sec. or tax I.D. No.) 

and irrevocably appoint                     agent to
transfer this Note on the books of the Issuer. The agent may substitute another to act for him. 
  

							
	  

				
	Date:		  
		Your Signature:		  

	
	  

	Sign exactly as your name appears on the other side of this Note.
					  

					Signature
	Signature Guarantee:				
			
	  
				  

	Signature must be guaranteed				Signature

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the
Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to,
or in substitution for, STAMP, all in accordance with the United States Securities Exchange Act of 1934, as amended. 

  
 70 

 SCHEDULE OF EXCHANGES OF NOTES 

The following exchanges of a part of this Global Note for Physical Notes or a part of another Global Note have been made: 

 

									
	 Date of Exchange
	 	 Amount of decrease in
principal amount of
this
Global Note
	 	 Amount of increase in
principal amount of
this
Global Note
	  	Principal amount of this
Global Note following
such decrease (or
increase)	  	Signature of authorized
officer of Trustee
		 		 		  		  	
		 		 		  		  	

  
 71Exhibit 10.1

 

 

ADAPTIVE MEDIAS, INC.

 

COMMON STOCK AND WARRANT PURCHASE AGREEMENT

 

This COMMON STOCK AND
WARRANT PURCHASE AGREEMENT (this “Agreement”) is made as of April 30, 2015 between ADAPTIVE MEDIAS, Inc., a
Nevada corporation (the “Company”), and James Batmasian (the “Purchaser”).

 

 

WHEREAS, the Company
desires to sell and issue to the Purchaser, and the Purchaser desires to purchase from the Company, under the terms and conditions
stated in this Agreement, (a) shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”),
for an aggregate purchase price of Four Million Five Hundred Thousand Dollars ($4,500,000) (the “Shares”), to
be consummated in three separate Closings (as defined below) at a price per share equal to eighty percent (80%) of the volume weighted
average closing price per share for the twenty (20) consecutive trading days immediately preceding the Initial Closing Date (as
defined below) (the “Purchase Price”), (b) a warrant to purchase an aggregate of 1,331,361 shares of Common
Stock (“Warrant A”) at a price of $1.69 per share (the “Warrant A Exercise Price”) and (c)
a warrant to purchase 500,000 shares of Common Stock (“Warrant B”) at a price of $3.00 per share (the “Warrant
B Exercise Price”) (collectively Warrant A and Warrant B referred to as the “Warrants,” and collectively
with the Shares, the “Units”).

 

NOW, THEREFORE, in
consideration of the mutual covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the parties hereto hereby agree as follows:

 

AGREEMENT

 

1.           Definitions.
In addition to the terms defined elsewhere in this Agreement, for purposes of this Agreement the following terms shall have
the meaning indicated in this Section 1:

 

“Action”
means any action, suit, inquiry, notice of violation, proceeding (including any partial proceeding such as a deposition) or investigation
pending or, to the Company’s Knowledge, threatened in writing against the Company, any Subsidiary or any of their respective
properties or any officer, director or employee of the Company or any Subsidiary acting in his or her capacity as an officer, director
or employee before or by any Governmental Entity.

 

“Affiliate”
means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls,
is controlled by or is under common control with such Person.

 

“Business
Day” means a day, other than a Saturday or Sunday, on which banks in New York City are open for the general transaction
of business.

 

 

    	 

    	 

    

 

“Code”
means the Internal Revenue Code of 1986, as amended, including the regulations and published interpretations thereunder.

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Company’s
Knowledge” means with respect to any statement made to the knowledge of the Company, that the statement is based upon
the present, actual knowledge of the executive officers of the Company having responsibility for the matter or matters that are
the subject of the statement.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations promulgated
thereunder.

 

“Governmental
Entity” means any governmental or regulatory authorities, agencies, arbitrators, courts, commissions or other entities,
whether federal, state, local or foreign, or applicable self-regulatory organizations.

 

“Law”
means any federal, state, county, municipal or local ordinance, permit, concession, grant, franchise, law, statute, code, rule
or regulation or any judgment, ruling, order, writ, injunction or decree promulgated by any Governmental Entity.

 

“Person”
means an individual, corporation, partnership, limited liability company, trust, business trust, association, joint stock company,
joint venture, sole proprietorship, unincorporated organization or Governmental Entity.

 

“Principal
Market” means the Trading Market on which the Common Stock is primarily listed on and quoted for trading, which, as of
the Closing Date, shall be the OTCQB.

 

“Securities Act” means
the Securities Act of 1933, as amended.

 

“Subsidiary”
means those corporations and other entities of which such Person owns or controls 50% or more of the outstanding equity securities
either directly or indirectly through an unbroken chain of entities as to each of which 50% or more of the outstanding equity securities
is owned directly or indirectly by its parent or otherwise controlled by such parent.

 

“Tax”
or “Taxes” means (i) any federal, state, local or foreign income, gross receipts, property, sales, use, license,
excise, franchise, employment, payroll, withholding, alternative or add on minimum, ad valorem, transfer or excise tax, or any
other tax, custom, duty, governmental fee or other like assessment or charge of any kind whatsoever, together with any interest
or penalty, imposed by any Governmental Entity and (ii) any liability in respect of any items described in clause (i) above payable
by reason of contract, assumption, transferee or successor liability, operation of law or otherwise.

 

    	 

    	 

    

 

“Tax Return”
means any return, declaration, report or similar statement filed or required to be filed with respect to any Tax (including any
attached schedules), including, without limitation, any information return, claim for refund, amended return or declaration of
estimated Tax.

 

“Trading Day”
means (i) a day on which the Common Stock is listed or quoted and traded on its Principal Market or (ii) if the Common Stock is
not quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported in the “pink
sheets” by OTC Markets Group Inc. (or any similar organization or agency succeeding to its functions of reporting prices);
provided, that in the event that the Common Stock is not listed or quoted as set forth in (i) and (ii) hereof, then Trading
Day shall mean a Business Day.

 

“Transaction
Documents” means this Agreement, the schedules and exhibits attached hereto, and any other documents or agreements executed
in connection with the transactions contemplated hereunder.

 

“Transfer
Agent” means VStock Transfer, LLC or any successor transfer agent for the Company.

 

2.           Closings; Payment
and Delivery.

 

(a)           Closings.
The sale and issuance of the Shares, Warrant A and Warrant B to the Purchaser and the purchase of such Shares, Warrant A and Warrant
B by the Purchaser shall take place at three (3) separate closings (each, a “Closing”) at the offices of the
Company’s counsel at such times (each, a “Closing Date”) as set forth below:

 

		(i)	The initial closing (the “Initial Closing”) shall occur on the date that is
(2) business days following the day on which the conditions set forth in Section 8 (other than those that in nature are
to be satisfied at the Initial Closing, but subject to the fulfillment or waiver of these conditions) are satisfied or waived by
the Purchaser. At the Initial Closing, (A) the Purchaser will deliver to the Company the Purchaser Deliverables in accordance with
Section 3(b) herein and an aggregate Purchase Price equal to Two Million Dollars ($2,000,000); and (B) the Company will
deliver to the Purchaser the Company Deliverables in accordance with Section 3(a) herein and shall instruct its Transfer
Agent to issue and deliver to the Purchaser evidence of ownership of the number of Shares in accordance with the Recitals herein.

 

		(ii)	The second closing (the “Second Closing”) shall occur upon the earlier of (A)
the consummation of a definitive merger transaction with Beanstock Media (“Beanstock”), whereby Beanstock shall
merge with and into a wholly owned subsidiary of the Company (the “Merger”); and (B) forty-five (45) business
days following the Initial Closing; provided, however, that the Purchaser shall not be required to effectuate the Second Closing
if the Merger has not first been effectuated or is not effectuated concurrently with the Second Closing. At the Second Closing,
(1) the Purchaser will deliver to the Company an aggregate Purchase Price equal to One Million Dollars ($1,000,000); and (2) the
Company shall instruct its Transfer Agent to issue and deliver to the Purchaser evidence of ownership of the number of Shares in
accordance with the Recitals herein.

 

    	 

    	 

    

 

		(iii)	The third closing (the “Third Closing”) shall occur upon the earlier of (A)
the Company’s initial filing of a Form S-1 Registration Statement with the United States Securities and Exchange Commission
(the “Commission”) in connection with an anticipated uplisting of its Common Stock to the Nasdaq Stock Market,
Inc. (the “S-1 Filing”); and (B) forty-five (45) business days following the Second Closing; provided, however,
that the Purchaser shall not be required to effectuate the Third Closing if (1) the Second Closing has not first been effectuated
and (2) the S-1 Filing has not been made with the Commission or is not made concurrently with the Third Closing. At the Third Closing,
(a) the Purchaser will deliver to the Company an aggregate Purchase Price equal to One Million Five Hundred Thousand Dollars ($1,500,000);
and (b) the Company shall instruct its Transfer Agent to issue and deliver to the Purchaser evidence of ownership of the number
of Shares in accordance with the Recitals herein.

 

(b)           Payment and
Delivery. At each Closing, the Company shall instruct its Transfer Agent to issue and deliver to the Purchaser evidence of
ownership of the Shares and/or a copy of the Company’s irrevocable instructions to its Transfer Agent to prepare and issue
such Shares, and, in connection with the Initial Closing only, the executed Warrants. The Purchaser shall pay the applicable Purchase
Price at each Closing by (i) a check payable to the Company’s order, (ii) wire transfer of funds to an account designated
by the Company or (iii) any combination of the foregoing, subject to reasonable prior notification.

 

3.           Initial Closing Deliverables.

 

(a)           On or prior to
the Initial Closing, the Company shall issue, deliver or cause to be delivered to the Purchaser (unless otherwise indicated) the
following (the “Company Deliverables”):

 

 (i)           this Agreement, duly executed by the Company;

 

(ii)           Warrant A evidencing
the warrant to purchase an aggregate of 1,331,361 shares of Common Stock (“Warrant A”) at a price of $1.69 per
share (the “Warrant A Exercise Price”) in substantially the form of warrant attached hereto as Exhibit C;

 

 

(iii)           Warrant B
evidencing the warrant to purchase an aggregate of a 500,000 shares of Common Stock (“Warrant B”) at a price
of $3.00 per share (the “Warrant B Exercise Price”) in substantially the form of warrant attached hereto as
Exhibit C;

 

 

    	 

    	 

    

 

(iv)           An at-will
employment, confidential information, invention assignment and arbitration agreement duly executed by the Company and James Waltz;
in the form attached hereto as Exhibit D;

 

(v)           a certificate
of the President of the Company (the “President’s Certificate”), dated as of the Closing Date, (a) certifying
the resolutions adopted by the Board of Directors of the Company (the “Board”) or a duly authorized committee
thereof approving the transactions contemplated by this Agreement and the issuance of the Shares and Warrants, (b) certifying the
current versions of the articles of incorporation and bylaws, as amended, of the Company and (c) certifying as to the signatures
and authority of persons signing this Agreement and related documents on behalf of the Company;

 

(vi)           a certificate
of the Chief Executive Officer, President or Chief Financial Officer of the Company, dated as of the Closing Date, certifying to
the fulfillment of the conditions specified in Section 8(a)(i) and Section 8(a)(ii);

 

(vii)           a Certificate
of Good Standing for the Company from the Nevada Secretary of State as of a recent date; and

 

(viii)           an annual
operating budget for the Company for the next succeeding calendar year presented on a monthly basis consistent with the annual
operating statement described by the Company to the Purchaser, including cash flow projections and use of proceeds from the Purchase
Price (the “Budget”).

 

(b)           On or prior to
the Initial Closing, the Purchaser shall deliver or cause to be delivered to the Company the following (the “Purchaser
Deliverables”):

 

(i)           this Agreement, duly executed by
such Purchaser; and

 

(ii)           fully completed
and duly executed Accredited Investor Questionnaire reasonably satisfactory to the Company, and Stock Certificate Questionnaire
in the forms attached hereto as Exhibit B and Exhibit A, respectively.

 

4.           Representations
and Warranties of the Company. The Company hereby represents and warrants to, and covenants with, the Purchaser that except
as set forth in the Company’s public filings with the Commission available at http://www.sec.gov:

 

(a)           Subsidiaries.
The Company owns, directly or indirectly, all of the capital stock (except for any preferred securities issued by Subsidiaries
that are trusts) or comparable equity interests of each Subsidiary free and clear of any and all liens, and all the issued and
outstanding shares of capital stock or comparable equity interest of each Subsidiary are validly issued and are fully paid, non-assessable
(to the extent such concept is applicable to an equity interest of a Subsidiary) and free of preemptive and similar rights to subscribe
for or purchase securities.

 

    	 

    	 

    

 

(b)           Organization,
Good Standing and Qualification. The Company and each of its Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the Laws of the jurisdiction of its incorporation or organization (as applicable) and
has all requisite corporate power and authority to own and operate its respective properties and assets and to carry on its respective
businesses as now conducted and as proposed to be conducted. Neither the Company nor any of its Subsidiaries is in violation of
any of the provisions of their respective articles of incorporation, bylaws or other organizational documents. The Company and
each of its Subsidiaries is duly qualified to transact business and is in good standing in each jurisdiction in which qualification
is required, except where the failure to so qualify, individually or in the aggregate, would not have a material adverse effect
on the Company or any of its Subsidiaries.

 

(c)           Authorization.
The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this
Agreement and the other Transaction Documents and otherwise to carry out its obligations hereunder or thereunder, including without
limitation, to issue the Shares in accordance with the terms hereof, to issue the Warrants in accordance with the terms and any
shares of Common Stock issuable upon exercise of the Warrants. The execution and delivery of this Agreement and other Transaction
Documents by the Company, the consummation by it of the transactions contemplated hereby or thereby and the authorization, issuance,
sale and delivery of the Units pursuant to this Agreement have been duly authorized by all necessary corporate action on the part
of the Company, and no further corporate action is required by the Company, its Board of Directors or its shareholders in connection
therewith. This Agreement has been (or upon delivery will be) and upon delivery the other Transaction Documents will be duly executed
by the Company and, when delivered in accordance with the terms hereof, will constitute the valid and binding obligation of the
Company enforceable against the Company in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and similar laws affecting creditors’ rights and remedies generally and general principles
of equity. There are no shareholder agreements, voting agreements, or similar arrangements with respect to the Company’s
capital stock to which the Company is a party to, or to the Company’s Knowledge, between or among any of the Company’s
shareholders.

 

(d)           No Conflicts.
The execution, delivery and performance by the Company of this Agreement or the other Transaction Documents and the consummation
by the Company of the transactions contemplated hereby (including, without limitation, the issuance of the Shares and the Warrants
and shares of Common Stock issuable upon exercise of the Warrants) do not and will not (i) conflict with or violate any provisions
of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or otherwise result in a violation
of the organizational documents of the Company or any Subsidiary, (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would result in a default) under, result in the creation of any lien upon any of the properties
or assets of the Company or any Subsidiary or give to others any rights of termination, amendment, acceleration or cancellation
(with or without notice, lapse of time or both) of, any agreement, instrument or binding obligation of the Company or any Subsidiary,
or (iii) conflict with or result in a violation of any Law of any Governmental Entity to which the Company or any Subsidiary is
subject (including federal and state securities Laws and rules), or by which any property or asset of the Company or any Subsidiary
is bound or affected, except in the case of clauses (ii) and (iii) such as would not have or reasonably be expected to have, individually
or in the aggregate, a material adverse effect.

 

    	 

    	 

    

 

           (e)           Filings, Consents and Approvals. Neither the Company nor any
Subsidiary is required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration
with, any Governmental Entity or other Person in connection with the execution, delivery and performance by the Company of this
Agreement (including, without limitation, the issuance of the Shares and the Warrants and shares of Common Stock issuable upon
exercise of the Warrants), other than filings required by applicable federal and state securities Laws.

 

(f)           Valid Issuance
of Units. The Units have been duly authorized and, when issued, sold and delivered in accordance with the terms of this Agreement
for the consideration set forth here-in, will be duly and validly issued, fully paid, and nonassessable and free of all liens and
restrictions on transfer other than the restrictions on transfer contained in this Agreement and other Transaction Documents and
under applicable state and federal securities laws. The issuance of the shares of Common Stock issuable upon exercise of the Warrants,
if and when issued in accordance with the terms of the articles of incorporation of the Company, will be validly issued fully paid,
and nonassessable and free of all liens and restrictions on transfer other than the restrictions on transfer contained in this
Agreement and other Transaction Documents and under applicable state and federal securities laws and not be subject to preemptive
or similar rights.

 

(g)           SEC Reports;
Financial Statements. The Company has filed all reports required to be filed by it under the Securities Act and the Exchange
Act for the two years preceding the date hereof (or such shorter period as the Company was required by law to file such material)
(the foregoing materials being collectively referred to herein as the “SEC Reports”). Except for the Quarterly
Report on Form 10-Q for the quarter ended March 31, 2011 and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2011
which were amended in 2012, and the Annual Report on Form 10-K for the year ended December 31, 2014, which was amended in April
2015 (the “Amended Reports”), as of their respective dates, the SEC Reports complied in all material respects
with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder,
and except as set forth in the Amended Reports, none of the SEC Reports, when filed, to Company’s Knowledge, contained any
untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to
make the statements therein, in light of the circumstances under which they were made, not misleading. Except as set forth in the
Amended Reports, the financial statements of the Company included in the SEC Reports comply in all material respects with applicable
accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing.
Except as set forth in the Amended Reports, such financial statements have been prepared in accordance with generally accepted
accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise
specified in such financial statements or the notes thereto, and fairly present in all material respects the financial position
of the Company as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject,
in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

 

    	 

    	 

    

 

(h)           Capitalization.
(1) The authorized capital stock of the Company consists of 300,000,000 shares of Common Stock, par value $0.001 per share, of
which 13,981,579 shares are issued and outstanding as of the date hereof. All of the outstanding shares of capital stock of the
Company are duly authorized, validly issued, fully paid and non-assessable, have been issued in compliance in all material respects
with all applicable federal and state securities Laws, and none of such outstanding shares was issued in violation of any preemptive
rights or similar rights to subscribe for or purchase any capital stock of the Company. No shares of the Company’s outstanding
capital stock are subject to preemptive rights or any other similar rights; (ii) there are no outstanding options or other equity-based
rights, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or
rights convertible into, or exercisable or exchangeable for, or evidencing the right to subscribe for, purchase or receive any
shares of capital stock of the Company, or contracts, commitments, understandings or arrangements by which the Company is or may
become bound to issue additional shares of capital stock of the Company or options or other equity-based awards, warrants, scrip,
rights to subscribe to, calls, agreements, arrangements or commitments of any character whatsoever relating to, or securities or
rights convertible into, or exercisable or exchangeable for, any shares of capital stock of the Company; (iii) there are no material
outstanding debt securities, notes, credit agreements, credit facilities or other agreements, arrangements, commitments, documents
or instruments evidencing indebtedness of the Company or by which the Company is bound; (iv) there are no agreements, commitments,
understandings or arrangements under which the Company is obligated to register the sale of any of its securities under the Securities
Act; (v) there are no outstanding securities or instruments, agreements, commitments, understandings or arrangements of the Company
that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which
the Company is or may become bound to sell, transfer, dispose of, repurchase or redeem a security of the Company; (vi) the Company
does not have any stock appreciation rights or “phantom stock” plans or agreements or any similar plan or agreement.
There are no securities or instruments of the Company containing anti-dilution or similar provisions that will be triggered by
the issuance of the Units, except with respect to certain stock purchase warrants issued to certain investors from time to time.
Each option to purchase shares of Common Stock was granted with an exercise price per share equal to or greater than the per share
fair market value (as such term is used in Code Section 409A and the Department of Treasury regulations and other interpretive
guidance issued thereunder) of the Common Stock underlying such option on the grant date thereof and was otherwise issued in compliance
with the requirements of the Code and applicable Laws. Each option to purchase shares of Common Stock that was issued as an “incentive
stock option” pursuant to Section 422 of the Code complied at the time of its grant and continues to comply with all of the
requirements of the Code and the regulations thereunder pertaining to “incentive stock options.”

 

(2)           Immediately following
the Initial Closing, (i) 15,165,011 shares of Common Stock, subject to increase for the exercise of options to acquire Common Stock
will be issued and outstanding as of the date hereof.

 

    	 

    	 

    

 

(i)           Tax Matters.
The Company and each of its Subsidiaries has (i) timely filed all material foreign, U.S. federal, state and local Tax Returns that
are or were required to be filed, and all such Tax Returns are true, correct and complete in all material respects, (ii) paid all
material Taxes required to be paid by it and any other material assessment, fine or penalty levied against it, whether or not shown
or determined to be due on such Tax Returns, other than any such amounts (x) currently payable without penalty or interest, or
(y) being contested in good faith by appropriate proceedings and for which adequate reserves have been established in accordance
with GAAP; (iii) timely withheld, collected or deposited as the case may be all material Taxes (determined both individually and
in the aggregate) required to be withheld, collected or deposited by it, and to the extent required, have been paid to the relevant
taxing authority in accordance with applicable Law; and (iv) complied with all applicable information reporting requirements in
all material respects. Neither the Company nor any Subsidiary is (i) subject to any outstanding audit, assessment, dispute or claim
concerning any material Tax liability of the Company or any of its Subsidiaries either within the Company’s Knowledge or
claimed, pending or raised by an authority in writing; or (ii) a party to, bound by or otherwise subject to any obligation under
any Tax sharing or Tax indemnity agreement or similar contract or arrangement (other than an agreement, similar contract or arrangement
to which only the Company and its Subsidiaries are parties). Neither the Company nor any subsidiary has (i) participated in a “listed
transaction” within the meaning of Treasury Regulation Section 1.6011- 4(b)(2); or (ii) has any liability for Taxes of any
Person arising from the application of Treasury Regulation Section 1.1502-6 or any analogous provision of state, local or foreign
Law, or as a transferee or successor, by contract, or otherwise. No claim has been made by a tax authority in a jurisdiction where
the Company does not pay Taxes or file Tax Returns asserting that the Company or any Subsidiary is or may be subject to Taxes assessed
by such jurisdiction. Neither the Company nor any Subsidiary will not be required to include any item of income in, or exclude
any item of deduction from, taxable income for any period (or any portion thereof) ending after the Closing as a result of any:
(1) installment sale or other open transaction disposition made on or prior to the Closing; (2) prepaid amount received on or prior
to the Closing; (3) written and legally binding agreement with a governmental authority relating to taxes for any taxable period
ending on or before the Closing; (4) change in method of accounting in any taxable period ending on or before the Closing; or (5)
election under Section 108(i) of the Code.

 

(j)           Environmental
Matters. To the Company’s Knowledge, neither the Company nor any Subsidiary (i) is in violation of any Law of any Governmental
Entity relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration of
the environment or human exposure to hazardous or toxic substances (collectively, “Environmental Laws”), (ii)
is liable for any off-site disposal or contamination pursuant to any Environmental Laws, (iii) owns or operates any real property
contaminated with any substance that is in violation of any Environmental Laws or (iv) is subject to any claim relating to any
Environmental Laws; in each case, which violation, contamination, liability or claim has had or would reasonably be expected to
have, individually or in the aggregate, a material adverse effect; and there is no pending or, to the Company’s Knowledge,
threatened investigation that might lead to such a claim. To the Company’s Knowledge, except as would not result in a material
adverse effect, there are no circumstances or conditions (including the presence of asbestos, underground storage tanks, lead products,
polychlorinated biphenyls, prior manufacturing operations, dry-cleaning or automotive services) involving the Company, any Subsidiary
or any currently or formerly owned or operated property of the Company or any Subsidiary that could reasonably be expected to result
in any claim, liability, investigation, cost or restriction against the Company or any Subsidiary or result in any restriction
on the ownership, use, or transfer of any property pursuant to any Environmental Law, or adversely affect the value of any currently
owned property of the Company or any Subsidiary.

 

    	 

    	 

    

 

(k)           Litigation.
There is no Action which (i) adversely affects or challenges the legality, validity or enforceability of any part of this Agreement
or other Transaction Documents (or the transactions contemplated thereby), the issuance of the Shares, the Warrants or the shares
of Common Stock issuable upon exercise of the Warrants or (ii) has had or is reasonably likely to have a material adverse effect,
individually or in the aggregate, if there were an unfavorable decision. Neither the Company, nor any Subsidiary, nor any director
or officer thereof in their capacity as a director or officer of the Company or any Subsidiary is not or has been the subject of
any Action involving a claim of violation of or liability under federal or state securities Laws or a claim of breach of fiduciary
duty relating to the Company. There has not been, and to the Company’s Knowledge there is not pending or contemplated, any
investigation by the Commission involving the Company, any Subsidiary or any current or former director or officer of the Company
or any Subsidiary. There are no outstanding orders, judgments, injunctions, awards or decrees of any Governmental Entity against
the Company or any Subsidiary or any executive officers or directors of the Company or any Subsidiary in their capacities as such,
which individually or in the aggregate, would reasonably be expected to have a material adverse effect.

 

(l)           Compliance.
Neither the Company nor any of its Subsidiaries (i) is in default under or in violation of (and no event has occurred that has
not been waived that, with notice or lapse of time or both, would result in a default by the Company or any of its Subsidiaries
under), nor has the Company or any of its Subsidiaries received written notice of a claim that it is in default under or that it
is in violation of, any material contract (whether or not such default or violation has been waived), or (ii) is in violation of
any order of which the Company has been made aware in writing of any court, arbitrator or Governmental Entity having jurisdiction
over the Company, its Subsidiaries or their respective properties or assets, except in each case set forth in (i), and (ii) of
this paragraph as would not have or reasonably be expected to have, individually or in the aggregate, a material adverse effect.

 

(m)           Regulatory
Permits. The Company and each of its Subsidiaries possess or have applied for all certificates, authorizations, consents, licenses,
franchises, variances, exemptions, orders, approvals and permits issued by the appropriate Governmental Entities necessary to conduct
their respective businesses as currently conducted and that are material to the business of the Company or such of its Subsidiaries,
except where the failure to possess such certificates, authorizations or permits, individually or in the aggregate, has not and
would not reasonably be expected to have, individually or in the aggregate, a material adverse effect (“Material Permits”),
and (i) neither the Company nor any of its Subsidiaries has received any notice in writing of proceedings relating to the revocation
or material adverse modification of any such Material Permits and (ii) the Company is unaware of any facts or circumstances that
would give rise to the suspension, revocation or material adverse modification of any Material Permits.

 

(n)           Title to Assets.
The Company and its Subsidiaries have good and marketable title to all real property and tangible personal property owned by them
which is material to the business of the Company and its Subsidiaries, taken as a whole, in each case free and clear of all liens
except such as do not materially affect the value of such property or do not interfere with the use made and proposed to be made
of such property by the Company and any of its Subsidiaries. Any real property and facilities held under lease by the Company and
any of its Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material
and do not interfere with the use made and proposed to be made of such property and facilities by the Company and its Subsidiaries.
No notice of a claim of default by any party to any lease entered into by the Company or any of its Subsidiaries has been delivered
to either the Company or any of its Subsidiaries or is now pending, and there does not exist any event or circumstance that with
notice or passing of time, or both, would constitute a default or excuse performance by any party thereto. None of the owned or
leased premises or properties of the Company or any of its Subsidiaries is subject to any current or potential interests of third
parties or other restrictions or limitations that would impair or be inconsistent in any material respect with the current use
of such property by the Company or any of its Subsidiaries, as the case may be.

 

    	 

    	 

    

 

(o)           Patents and
Trademarks. The Company and its Subsidiaries own, possess, license, or can acquire on reasonable terms, or have other rights
to use all foreign and domestic patents, patent applications, trade and service marks, trade and service mark registrations, trade
names, copyrights, inventions, trade secrets, technology, Internet domain names, know-how and other intellectual property (collectively,
the “Intellectual Property”) necessary for the conduct of their respective businesses as now conducted, except
where the failure to own, possess, license or have such rights would not have or reasonably be expected to have a material adverse
effect. Except where such violations or infringements would not have or reasonably be expected to have, either individually or
in the aggregate, a material adverse effect, (a) other than with respect to licensed Intellectual Property, there are no rights
of third parties to any such Intellectual Property; (b) there is no infringement by third parties of any such Intellectual Property;
(c) there is no pending or, to the Company’s Knowledge, threatened action, suit, proceeding or claim by others challenging
the Company’s and its Subsidiaries’ rights in or to any such Intellectual Property (other than licensed Intellectual
Property in which case to the Company’s Knowledge there is no such action suit, proceeding or claim by others pending or
threatened); (d) there is no pending or, to the Company’s Knowledge, threatened action, suit, proceeding or claim by others
challenging the validity or scope of any such Intellectual Property (other than licensed Intellectual Property in which case to
the Company’s Knowledge there is no such action suit, proceeding or claim by others pending or threatened); and (e) there
is no pending or, to the Company’s Knowledge, threatened action, suit, proceeding or claim by others that the Company and/or
any Subsidiary infringes or otherwise violates any patent, trademark, copyright, trade secret, or other proprietary rights of others.

 

(p)           Transactions
With Affiliates and Employees. Other than the grant of stock options or other equity awards that are not individually or in
the aggregate material in amount, none of the officers or directors of the Company and, to the Company’s Knowledge, none
of the employees or Affiliates of the Company, is presently a party to any contract, arrangement or transaction with the Company
(other than for services as employees, officers and directors) that would be required to be disclosed pursuant to Item 404 of Regulation
S-K promulgated under the Securities Act if the Common Stock was required to be registered with the Commission under the Securities
Act or the Exchange Act.

 

(q)           Investment
Company. Neither the Company nor any of its Subsidiaries is required to be registered as, and is not an Affiliate of, and immediately
following the Closing will not be required to register as, an “investment company” within the meaning of the Investment
Company Act of 1940, as amended, and neither the Company nor any Subsidiary sponsors any person that is such an investment company.

 

    	 

    	 

    

 

(r)           Unlawful Payments.
None of the Company or any of its Subsidiaries or its directors or officers or, to the Company’s Knowledge, any employees,
agents or other Persons acting at the direction of or on behalf of the Company or any of its Subsidiaries has, in the course of
its actions for, or on behalf of, the Company or any of its Subsidiaries: (a) directly or indirectly, used any corporate funds
for unlawful contributions, gifts, entertainment or other unlawful expenses relating to foreign or domestic political activity;
(b) made any direct or indirect unlawful payments to any foreign or domestic governmental officials or employees or to any foreign
or domestic political parties or campaigns from corporate funds; (c) violated any provision of the Foreign Corrupt Practices Act
of 1977, as amended; or (d) made any other unlawful bribe, rebate, payoff, influence payment, kickback or other material unlawful
payment to any foreign or domestic government official or employee.

 

(s)           Reservation
of Underlying Shares. The Company will reserve, free of any preemptive or similar rights of shareholders of the Company, a
number of unissued shares of Common Stock, sufficient to issue and deliver the shares of Common Stock for which the Warrants are
exercisable.

 

(t)           Change in Control.
The issuance of the Shares to the Purchaser as contemplated by this Agreement will not trigger any rights under any “change
of control” provision in any (i) employment, “change in control,” severance or other compensatory agreements
and any benefit plan, which results in payments to the counterparty or the acceleration of vesting of benefits or (ii) in any other
agreement to which the Company or any of its Subsidiaries is a party, other than as would not individually or in the aggregate
result in a material adverse effect.

 

(u)           Certain Fees.
The Company shall indemnify, pay, and hold the Purchaser harmless against, any liability, loss or expense (including, without limitation,
attorneys’ fees and out-of-pocket expenses) arising in connection with any right, interest or claim by any person as a result
of the transactions contemplated by this Agreement against or upon the Company for any commission, fee or other compensation pursuant
to any agreement, arrangement or understanding entered into by or on behalf of the Company.

 

(v)           Disclosure.
The Company has made available to the Purchaser all the information reasonably available to the Company that the Purchasers have
requested for deciding whether to acquire the Units. No representation or warranty of the Company contained in this Agreement and
other Transaction Documents and no certificate furnished or to be furnished to Purchaser at the Closing contains any untrue statement
of a material fact or omits to state a material fact necessary in order to make the statements contained herein or therein not
misleading in light of the circumstances under which they were made.

 

5. Representations
and Warranties of the Purchaser. The Purchaser hereby represents and warrants to the Company that:

 

(a)           Organization;
Validity; Enforcements. The Purchaser has the power, authority and capacity to enter into this Agreement and other Transactions
Documents and to consummate the transactions contemplated hereby and has taken all necessary action to authorize the execution,
delivery and performance of this Agreement and other Transaction Documents and upon the execution and delivery of this Agreement
and other Transaction Documents, this Agreement and other Transaction Documents shall constitute a legal, valid and binding obligation
of the Purchaser, enforceable in accordance with its terms.

 

    	 

    	 

    

 

(b)           Purchase Entirely
for Own Account. The Units are being acquired for investment for such Purchaser’s own account, not as a nominee or agent
and not with a view to the resale or distribution of any part thereof; provided, however, that by making this representation herein,
the Purchaser does not agree to hold any of the Units being acquired for any minimum period of time and reserves the right at all
times to sell or otherwise dispose of all or any part of such Units in compliance with applicable federal and state securities
Laws. The Purchaser does not have any agreement, plan or understanding, directly or indirectly, with any Person to distribute or
effect the distribution of the any of the Units, to or through any Person or entity.

 

(c)           Investment
Experience. Purchaser understands that the purchase of the Units involves substantial risk. Purchaser is an investor in securities
of companies in the developmental stage and acknowledges that Purchaser can bear the economic risk of Purchaser’s investment
and has such knowledge and experience in financial or business matters that Purchaser is capable of evaluating the merits and risks
of Purchaser’s investment in the Units. The Purchaser has undertaken an independent analysis of the merits and the risks
of an investment in the Units, based on the Purchaser’s own financial circumstances.

 

(d)           No General
Solicitation. Purchaser acknowledges that Purchaser became aware of the offering of Units, and the Units were offered to the
Purchaser, solely by direct contact between the Purchaser and the Company or the authorized representative of the Company and not
by other means, including any form of “general solicitation” or “general advertising” ( as such terms are
used in Regulation D promulgated under the Securities Act and interpreted by the Commission).

 

(e)           Accredited
Investor. Purchaser is an “accredited investor” within the meaning of Rule 501(a) under the Securities Act, as
presently in effect and Purchaser has completed and executed the Accredited Investor Questionnaire previously provided to the Purchaser.

 

(f)           Restricted
Units. Purchaser understands that the Units are characterized as “restricted securities” under the federal securities
laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such
laws and applicable regulations such securities may be resold without registration under the Securities Act only in certain limited
circumstances. In this connection, such Purchaser represents that Purchaser is familiar with the Rule 144 of the Securities Act,
as presently in effect, and understands the resale limitations imposed thereby. The Purchaser will not, directly or indirectly,
offer, sell, pledge, transfer or otherwise dispose of (or solicit any offers to buy, purchase or otherwise acquire or take a pledge
of) any of the Units, nor will the Purchaser engage in any short sale that results in a disposition of any of the Units by the
Purchaser, except in compliance with the Securities Act and the rules and regulations promulgated thereunder and any applicable
state securities law.

 

(g)           Consultation
With Own Attorney. Purchaser has been advised to consult with Purchaser’s own attorney or attorneys regarding all legal
matters concerning an investment in the Company and the tax consequences of purchasing the Units, and has done so, to the extent
the Purchaser considers necessary.

 

    	 

    	 

    

 

(h)           Tax Consequences.
Such Purchaser acknowledges that the tax consequences of investing in the Company will depend on particular circumstances, and
neither the Company, the Company’s officers, any other investors, nor the partners, shareholders, members, managers, agents,
officers, directors, employees, affiliates or consultants of any of them, will be responsible or liable for the tax consequences
to Purchaser of an investment in the Company. Such Purchaser will look solely to and rely upon Purchaser’s own advisers with
respect to the tax consequences of this investment.

 

(i)           Legends.
The Purchaser understands that until such time as the Shares may be sold pursuant to Rule 144 under the Securities Act without
any restriction as to the number of securities as of a particular date that can then be immediately sold, the Shares will bear
a restrictive legend in substantially the following form:

 

“THE SECURITIES REPRESENTED BY
THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR
SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER SUCH
ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR APPLICABLE
STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT TO RULE 144 OF SUCH ACT.”

 

(j)           Reliance on
Exemptions. The Purchaser understands that the Units are being offered and sold to Purchaser in reliance upon specific exemptions
from the registration requirements of the Securities Act, the rules and regulations promulgated thereunder and state securities
laws and that the Company is relying upon the truth and accuracy of, and the Purchaser’s compliance with, the representations,
warranties, agreements, acknowledgments and understandings of the Purchaser set forth herein in order to determine the availability
of such exemptions and the eligibility of the Purchaser to acquire the Units.

 

(k)           No
Government Review. The Purchaser understands that no United States federal or state agency or any other government or governmental
agency has passed upon or made any recommendation or endorsement of the Units.

 

6.           Other Agreements
of the Parties.

 

(a)           Removal of
Legends. The restrictive legend set forth in Section 5(i) above shall be removed and the Company shall issue a certificate
without such restrictive legend or any other restrictive legend to the holder of the applicable Shares upon which it is stamped
or issue to such holder by electronic delivery, as applicable, if (i) such Shares are registered for resale under the Securities
Act, (ii) such Shares are sold or transferred pursuant to Rule 144, or (iii) such Shares are eligible for sale under Rule 144.
Following the earlier of (i) the effective date of a registration statement or (ii) Rule 144 becoming available for the resale
of Shares, upon Purchaser’s delivery of a shareholder representation letter and any such documentation as may be required
by the Company’s counsel, the Company shall instruct the Transfer Agent to remove the legend from the Shares and shall cause
its counsel to issue any legend removal opinion required by the Transfer Agent. If a legend is no longer required pursuant to the
foregoing, the Company will no later than three (3) Trading Days following the delivery by a Purchaser to the Transfer Agent (with
notice to the Company) of a legended certificate or instrument representing such Shares (endorsed or with stock powers attached,
signatures guaranteed, and otherwise in form necessary to affect the reissuance and/or transfer) and a representation letter (such
third Trading Day, the “Legend Removal Date”), deliver or cause to be delivered to such Purchaser a certificate
or instrument (as the case may be) representing such Shares that is free from all restrictive legends. Certificates for Shares
free from all restrictive legends may be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser’s
prime broker with DTC as directed by such Purchaser. Except as may be required to ensure compliance with applicable law or so as
to be consistent with any insider trading policy implemented by the Company, and except as expressly provided in this Agreement
the Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on
transfer set forth in this Section 6(a).

 

    	 

    	 

    

 

(b)           Cooperation
by the Company. The Company shall cooperate, in accordance with reasonable and customary business practices with any and all
transfers, whether by direct or indirect sale, assignment, award, confirmation, distribution, bequest, donation, trust, pledge,
encumbrance, hypothecation, or other transfer or disposition, for consideration or otherwise, whether voluntary or involuntary,
by operation of law or otherwise, by the Purchaser or any of its successors and assigns of the Shares in accordance with this Agreement.

 

(c)           Right of First
Refusal. Any other provision of this Agreement notwithstanding, in the event and to the extent that the Company shall, during
the period commencing as of the date of this Agreement and terminating one (1) year from such date, offer to sell shares of its
Common Stock to any accredited investor, the Purchaser shall have a right-of-first refusal to purchase the same number of shares
of Common Stock at the same price offered by the Company to such accredited investor.

 

(d)           Anti-Dilution.
Any other provision of this Agreement notwithstanding, in the event and to the extent that the Company shall, during the period
commencing as of the date of this Agreement and terminating one (1) year from such date, sell shares of its Common Stock to any
accredited investor at a per share price that values the Company at less than $45 million (a “Dilutive Issuance”),
then the Company shall, within thirty (30) days therefrom, issue a sufficient number of shares of Common Stock, as applicable,
to the Purchaser (the “Subsequent Purchaser Issuance”), such that, following the Subsequent Purchaser Issuance,
Purchaser shall have received such number of shares of Common Stock as Purchaser would have obtained had this Agreement been entered
into on the same price terms as the Dilutive Issuance (calculated based on the aggregate purchase price set forth in the Recitals
of this Agreement). For the avoidance of doubt, this Section 6(d) shall not apply to (1) any debt incurred by the Company,
or (2) any stock, stock options, or stock purchase warrants issued to any employee, director or consultant of the Company in connection
with such employee’s or consultant’s compensation provided that such issuances are not priced lower than 20% below
the closing price of the stock on the day of issuance.

 

    	 

    	 

    

 

(e)           Appointment
of Director Position Following the Closing, the number of directors on the Board of Directors of the Company shall be increased
to four. Such new director shall be designated a nominee of the Purchaser and shall subsequently be approved by the Board of Directors
and by the shareholders of the Company as part of the annual meeting as provided for by the Company’s articles of incorporation
and bylaws.

 

(f)           Notice of Certain
Events. Each party shall promptly notify the other parties of (a) a breach of any representation or warranty contained herein
and (b) any event, condition, fact, circumstance, occurrence, transaction or other item of which such party becomes aware which
would have been required to have been disclosed pursuant to the terms of this Agreement or had such event, condition, fact, circumstance,
occurrence, transaction or other item existed as of the date hereof. Notwithstanding the foregoing, no party shall be required
to take any action that would jeopardize such party's attorney-client privilege.

 

(g)           Publicity.
Except as may be required by applicable Law, the Company will not, and will cause each of its Affiliates and representatives (including
its placement agent) not to, issue any press release or public statement that identifies the Purchaser or any investment adviser
to the Purchaser, or otherwise makes any public statement with respect to the Purchaser or any investment adviser to any Purchaser
without the prior written consent of the Purchaser. Any such press release or public statement required by applicable law shall
only be made by the Company after reasonable notice and opportunity for review by the Purchaser.

 

(h)           Warrants.
Purchaser may at any time and from time to time exercise Warrant A and/or Warrant B, in whole or in part, by delivering to the
Company the original Warrant together with a duly executed Notice of Exercise in the form attached to the Form of Warrant attached
hereto as Exhibit C and unless the Purchaser is exercising a cashless exercise pursuant to the Warrant, a check, wire transfer
of same-day funds (to an account designated by the Company), or other form of payment acceptable to the Company for the aggregate
warrant price (the “Warrant Funds”) for the shares of Common Stock being purchased by the exercise of such Warrant.

 

7.            Indemnification.

 

(a)           Indemnification
of Purchaser. The Company will indemnify and hold the Purchaser and Affiliates and investment advisers (and any other Persons
with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), (each,
a “Purchaser Indemnified Person”) harmless from and against any and all losses, liabilities, obligations, claims,
damages, costs and expenses actually and reasonably incurred by such Indemnified Person, including all judgments, amounts paid
in settlements, court costs and reasonable attorneys’ fees and costs of investigation (collectively, “Losses”)
that any such Purchaser Indemnified Person may suffer or incur as a result of (i) any breach of any of the representations, warranties,
covenants or agreements made by the Company in this Agreement or other Transaction Documents or (ii) any action instituted against
a Purchaser Indemnified Person in any capacity, or any of them or their respective Affiliates, by any shareholder of the Company
or other third party who is not a Purchaser, an Affiliate of a Purchaser, or an Affiliate of such Purchaser Indemnified Person,
with respect to any of the transactions contemplated by this Agreement or other Transaction Documents. The Company will not be
liable to any Purchaser Indemnified Person under this Agreement or other Transaction Documents to the extent, but only to the extent
that a loss, claim, damage or liability is attributable to any Purchaser Indemnified Person’s breach of any of the representations,
warranties, covenants or agreements made by such Indemnified Person in this Agreement or other Transaction Documents or attributable
to the actions or inactions of such Purchaser Indemnified Person. Any indemnification payment made pursuant to this Agreement shall
be treated as an adjustment to purchase price for Tax purposes, except as otherwise required by Law. Such payment shall not result
in an adjustment to the value of the original investment reported by the Company under GAAP.

 

    	 

    	 

    

 

(b)           Indemnification
of Company. After the Closing, the Purchaser shall indemnify and hold the Company and its directors, officers, shareholders,
members, partners, employees, and agents (and any other Persons with a functionally equivalent role of a Person holding such titles
notwithstanding a lack of such title or any other title), each Person who controls such the Company (within the meaning of Section
15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners,
or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack
of such title or any other title) of such controlling person (each a “Company Indemnified Person” and together
with the Purchaser Indemnified Parties, each an “Indemnified Person”) harmless from any and all Losses that
any such Company Indemnified Person may suffer or incur as a result of any breach of any of the representations, warranties, covenants
or agreements made by the Purchaser in this Agreement and other Transaction Documents. A Purchaser will not be liable to any Company
Indemnified Person under this Agreement or other Transaction Documents to the extent, but only to the extent, that a loss, claim,
damage or liability is attributable to any Company Indemnified Person’s breach of any of the representations, warranties,
covenants or agreements made by such Company Indemnified Person in this Agreement or other Transaction Documents or is attributable
to the actions or inactions of such Company Indemnified Person. The Purchaser will be liable, in the aggregate, to Company Indemnified
Persons for any amount in excess of the Purchase Price paid by the Purchaser. For purposes of clarity, the Purchaser shall not
be liable hereunder to any Company Indemnified Person with respect to any action taken by such Company Indemnified Person following
the Closing.

 

(c)           Conduct of
Indemnification Proceedings. Promptly after receipt by any Indemnified Person of notice of any demand, claim or circumstances
which would or might give rise to a claim or the commencement of any action, proceeding or investigation in respect of which indemnity
may be sought pursuant to Section 7(a) or Section 7(b), such Indemnified Person shall promptly notify the indemnifying
party in writing and the indemnifying party shall assume the defense thereof, including the employment of counsel reasonably satisfactory
to such Indemnified Person, and shall assume the payment of all fees and expenses; provided, however, that the failure of any Indemnified
Person so to notify the indemnifying party shall not relieve the indemnifying party of its obligations hereunder except to the
extent that the indemnifying party is actually and materially and adversely prejudiced by such failure to notify (as determined
by a court of competent jurisdiction, which determination is not subject to appeal or further review). In any such proceeding,
any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the
expense of such Indemnified Person unless: (i) the indemnifying party and the Indemnified Person shall have mutually agreed to
the retention of such counsel; (ii) the indemnifying party shall have failed promptly to assume the defense of such proceeding
and to employ counsel reasonably satisfactory to such Indemnified Person in such proceeding; or (iii) in the reasonable judgment
of counsel to such Indemnified Person, representation of both parties by the same counsel would be inappropriate due to actual
or potential differing interests between them; provided, that the indemnifying party shall not be liable for the fees and expenses
of more than one separate firm of attorneys at any time for all Indemnified Persons. The indemnifying party shall not be liable
for any settlement of any proceeding effected without its written consent, which consent shall not be unreasonably withheld, delayed
or conditioned. Without the prior written consent of the Indemnified Person, the indemnifying party shall not effect any settlement
of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnity
could have been sought hereunder by such Indemnified Person, unless such settlement includes an unconditional release of such Indemnified
Person from all liability arising out of such proceeding.

 

    	 

    	 

    

 

(d)           For purposes of
the indemnity contained in this Section 7 all qualifications and limitations set forth in the parties’ representations
and warranties as to “materiality,” “material adverse effect” and words of similar import shall be disregarded
in determining whether there shall have been any inaccuracy in or breach of any representations and warranties in this Agreement
and the Losses arising therefrom.

 

8.           Conditions
Precedent to Closing.

 

(a)           Conditions
Precedent to the Obligations of the Purchaser to Purchase Shares. The obligation of the Purchaser to acquire the Units at the
Closing is subject to the fulfillment, on or prior to the Closing Date, of each of the following conditions, any of which may be
waived by the Purchaser:

 

(i)           Representations
and Warranties. The representations and warranties of the Company made by the Company in Section 4 above shall be true
and correct in all material respects as of the Closing Date as though made on and as of such date, except for such representations
and warranties that speak as of a specific date (which representations and warranties are so true and correct as of such date).

 

(ii)           Performance.
The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by it at or prior to the Closing.

 

(iii)           No Injunction.
No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated
by this Agreement or other Transaction Documents.

 

(iii)           Consents.
The Company shall have obtained in a timely fashion any and all consents, permits, approvals, registrations and waivers necessary
for consummation of the purchase and sale of the Units, all of which shall be and remain so long as necessary in full force and
effect.

 

(iv)           Company
Deliverables. The Company shall have delivered the Company Deliverables in accordance with Section 3(a) above.

 

    	 

    	 

    

 

(v)           Budget.
The Budget shall be an accurate representation of what was described to Purchaser.

 

(b)           Conditions
Precedent to the Obligations of the Company to sell Units. The Company’s obligation to sell and issue the Units to the
Purchaser at the Closing is subject to the fulfillment on or prior to the Closing Date of the following conditions, any of which
may be waived by the Company:

 

(i)           Representations
and Warranties. The representations and warranties made by the Purchaser in Section 5 above shall be true and correct
in all material respects as of the Closing Date, except for such representations and warranties that speak as of a specific date
(which representations and warranties are so true and correct as of such date).

 

(ii)           Performance.
Such Purchaser shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by such Purchaser at or prior to the Closing Date.

 

(iii)           No Injunction.
No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated
by this Agreement or other Transaction Documents.

 

(iv)           Purchasers Deliverables.
Such Purchaser shall have delivered its Purchaser Deliverables in accordance with Section 3(b).

 

9.           Miscellaneous.

 

(a)           Piggyback Registration
Rights. The Company shall include on the next registration statement the Company files with the Commission (or on the subsequent
registration statement if such registration statement is withdrawn) all Shares issued under this Agreement. In the event a registration
statement is filed with respect to an underwritten offering or a selling stockholder registration statement relating solely to
holders of the Company’s Common Stock who paid cash for such Common Stock in a sale placed by an independent placement agent,
the number of shares of Common Stock owned by the Purchaser to be included in any such registration statement may be limited if
in the opinion of the underwriter or placement agent, the sale of such shares by the Purchaser would adversely impact the sale
of shares by the underwriter or selling stockholders included therein.

 

(b)           Survival of
Warranties. Subject to applicable statute of limitations, the warranties, representations and covenants of the Company and
the Purchaser contained in or made pursuant to this Agreement shall survive the execution and delivery of this Agreement and the
Closing; provided that the representations and warranties in Sections 4(a), 4(b), 4(c), 4(f), 4(g), 4(u) and 5(a)
shall survive indefinitely.

 

(c)           Fees
and Expenses. The Company shall pay the fees and expenses of the Purchaser’s advisers, counsel, accountants and other
experts, if any, and all other expenses incurred by the Purchaser incident to the negotiation, preparation, execution, delivery
and performance of this Agreement, the other Transaction Documents and the transactions contemplated thereby.

 

    	 

    	 

    

 

(d)           Successors
and Assigns. Except as otherwise provided herein, this Agreement shall be binding upon and inure to the benefit of the parties
and their successors and permitted assigns. This Agreement, or any rights or obligations hereunder, may not be assigned by the
Company without the prior written consent of the Purchaser. The Purchaser may assign his rights and obligations, in whole or in
part, to any Person to whom such Purchaser assignee or transfers Units or shares of Common Stock issuable upon exercise of the
Warrants in compliance with this Agreement and applicable Law, provided such transferee shall agree in writing to be bound, with
respect to the transferred Units or shares of Common Stock issuable upon exercise of the Warrants, by the terms and condition of
this Agreement that apply to the Purchaser.

 

(e)           No
Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

(f)           Governing
Law; Venue; Waiver of Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this
Agreement shall be exclusively governed by and construed and enforced in accordance with the internal laws of the Commonwealth
of Massachusetts, without regard to the principles of conflicts of law thereof. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts in the Commonwealth of Massachusetts for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement
of this Agreement), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that Purchaser
is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served
in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to Purchaser under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in
any way any right to serve process in any manner permitted by law. The parties hereby waive all rights to a trial by jury. If either
party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing party in such action
or proceeding shall be reimbursed by the other party for its attorney’s fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such action or proceeding.

 

(f)           Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being
understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission,
such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)
with the same force and effect as if such facsimile signature page were an original thereof.

 

    	 

    	 

    

 

(g)           Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

 

(h)           Entire
Agreement. This Agreement and the documents referred to herein constitute the entire agreement and understanding among the
parties hereto and supersede all prior negotiations and agreements, whether oral or written.

 

(i)           Notices.
Any notice or other communication required or permitted by this Agreement to be given to a party shall be in writing and shall
be deemed given if delivered personally or by commercial messenger or courier service, or mailed by U.S. registered or certified
mail (return receipt requested), or sent via email (with receipt of confirmation of complete transmission) to the party at the
party's email address written below or at such other address or facsimile number as the party may have previously specified by
like notice. If by mail, delivery shall be deemed effective three business days after mailing in accordance with this Section
9(i).

 

(1)           If to the Company,
to:

 

Adaptive Medias, Inc.

Attention: Omar Akram, President

16795 Von Karman, #240

Irvine, CA 92606

	Telephone:	(949) 525-4634
	Email:	omar@adaptivem.com

 

(2)           If to Purchaser,
to the address for notice on the signature page to this Agreement or, if no such address is provided, to the last address of Purchaser
provided by Purchaser to the Company with a copy to:

 

Greenberg Traurig, LLP

One International Place

Boston, MA 02110

	Facsimile:	(617) 310-6001
	Telephone:	(617) 310-6100
	Email:	greenbergg@gtlaw.com
	Attention:	Gary R. Greenberg, Esq.

 

And

 

Investments Limited

215 N. Federal Highway

Boca Raton, FL 33432

	Facsimile:	(561) 392-3561
	Telephone	(561) 392-8920
	Email:	jlazar@invementslimited.com
	Attention:	Jason Lazur, Esq.

 

    	 

    	 

    

 

(j)           Amendments;
Waivers; No Additional Consideration. No amendment or waiver of any provision of this Agreement will be effective with respect
to any party unless made in writing and signed by a duly authorized representative of such party.

 

(k)           Termination. This Agreement
may be terminated and the sale and purchase of the Units abandoned at any time prior to Closing:

 

(i)           by mutual written agreement by the
Company and the Purchaser;

 

(ii)           by the Purchaser
upon written notice to the Company, if (i) there has been a breach of any representation, warranty, covenant or agreement made
by the Company in this Agreement, or any such representation and warranty shall have become untrue after the date of this Agreement,
such that Section 8(a) would not be satisfied and (ii) such breach or condition is not curable or, if curable, is not cured
prior to the date that would otherwise be the Closing Date in absence of such breach or condition;

 

(iii)           by the Company,
upon written notice to the Purchaser, if (i) there has been a breach of any representation, warranty, covenant or agreement made
by the Purchaser in this Agreement, or any such representation and warranty shall have become untrue after the date of this Agreement,
such that Section 8(b) would not be satisfied and (ii) such breach or condition is not curable or, if curable, is not cured
prior to the date that would otherwise be the Closing Date in absence of such breach or condition; and

 

(iv)           by any party, upon written notice
to the other parties, in the event that any Governmental Entity shall have issued any order, decree or injunction or taken any
other action restraining, enjoining or prohibiting any of the transactions contemplated by this Agreement, and such order, decree,
injunction or other action shall have become final and nonappealable.

 

(l)           Effects of
Termination. In the event of any termination of this Agreement as provided in Section 9(k) above, this Agreement (other
than Section 7 and this Section 9, which shall remain in full force and effect) shall forthwith become wholly void
and of no further force and effect; provided, that nothing herein shall be deemed to release any party from any liability for any
breach by such party of the terms and provisions of this Agreement or to impair the right of any party to compel specific performance
by any other party of its obligations under this Agreement.

 

(m)           Severability.
If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the
remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt
to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate
such substitute provision in this Agreement.

 

(n)           Replacement
of Units. If any certificate or instrument evidencing any Units is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor,
a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company and the Transfer Agent
of such loss, theft or destruction and the execution by the holder thereof of a customary lost certificate affidavit of that fact
and an agreement to indemnify and hold harmless the Company and the Transfer Agent for any losses in connection therewith and,
if required by the Transfer Agent, a bond in such form and amount as is required by the Transfer Agent. The applicants for a new
certificate or instrument under such circumstances shall also pay any reasonable third-party costs associated with the issuance
of such replacement Units. If a replacement certificate or instrument evidencing any Units is requested due to a mutilation thereof,
the Company may require delivery of such mutilated certificate or instrument as a condition precedent to any issuance of a replacement.

 

    	 

    	 

    

 

(o)           Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Purchaser
and the Company shall be entitled to specific performance under this Agreement. The parties agree that monetary damages may not
be adequate compensation for any loss incurred by reason of any breach of obligations described in the foregoing sentence and hereby
agree to waive in any action for specific performance of any such obligation (other than in connection with any action for a temporary
restraining order) the defense that a remedy at law would be adequate.

 

[Signature Page Follows]

 

    	 

    	 

    

 

 

IN WITNESS WHEREOF, the parties hereto have
caused this Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

 

	 	COMPANY:
	 	 	 
	 	ADAPTIVE MEDIAS, INC.
	 	 	 
	 	 	 
	 	By:	/s/ Omar Akram	 
	 	 	Name: Omar Akram
	 	 	Title: President and Chief Financial
	 	 	Officer
	 	 	 
	 	 	 
	 	PURCHASER:
	 	 	 
	 	 	 
	 	James Batmasian	 
	 	Purchaser Name (Print)	 
	 	 	 
	 	 /s/ James Batmasian	 

 

  

	Address:	215 North Federal Highway
	 	Boca Raton, FL 33432
	Telephone:	 
	Facsimile:	 
	E-mail:	 

 

    	 

    	 

    

 

Exhibit A

 

Stock Certificate Questionnaire

 

 

 

 

 

    	 

    	 

    

 

Exhibit B

 

Accredited Investor Questionnaire

 

 

 

 

 

    	 

    	 

    

 

Exhibit C

 

Form of Warrant

 

 

 

 

 

 

    	 

    	 

    

 

Exhibit D

 

At-Will Employment, Confidential Information,

 

Invention Assignment and Arbitration Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}]]